Article:Sexual dimorphism in bacterial infections. (6011518)

From ScienceSource
Jump to: navigation, search

This page is the ScienceSource HTML version of the scholarly article described at Its title is Sexual dimorphism in bacterial infections. and the publication date was 2018-06-20. The initial author is Edgar Ricardo Vázquez-Martínez.

Fuller metadata can be found in the Wikidata link, which lists all authors, and may have detailed items for some or all of them. There is further information on the article in the footer below. This page is a reference version, and is protected against editing.

Converted JATS paper:

Journal Information

Title: Biology of Sex Differences

Sexual dimorphism in bacterial infections

  • Edgar Ricardo Vázquez-Martínez
  • Elizabeth García-Gómez
  • Ignacio Camacho-Arroyo
  • Bertha González-Pedrajo

Publication date (epub): 6/2018

Publication date (pmc-release): 6/2018

Publication date (collection): /2018



Sex differences are important epidemiological factors that impact in the frequency and severity of infectious diseases. A clear sexual dimorphism in bacterial infections has been reported in both humans and animal models. Nevertheless, the molecular mechanisms involved in this gender bias are just starting to be elucidated. In the present article, we aim to review the available data in the literature that report bacterial infections presenting a clear sexual dimorphism, without considering behavioral and social factors.

Main body

The sexual dimorphism in bacterial infections has been mainly attributed to the differential levels of sex hormones between males and females, as well as to genetic factors. In general, males are more susceptible to gastrointestinal and respiratory bacterial diseases and sepsis, while females are more susceptible to genitourinary tract bacterial infections. However, these incidences depend on the population evaluated, animal model and the bacterial species. Female protection against bacterial infections and the associated complications is assumed to be due to the pro-inflammatory effect of estradiol, while male susceptibility to those infections is associated with the testosterone-mediated immune suppression, probably via their specific receptors. Recent studies indicate that the protective effect of estradiol depends on the estrogen receptor subtype and the specific tissue compartment involved in the bacterial insult, suggesting that tissue-specific expression of particular sex steroid receptors contributes to the susceptibility to bacterial infections. Furthermore, this gender bias also depends on the effects of sex hormones on specific bacterial species. Finally, since a large number of genes related to immune functions are located on the X chromosome, X-linked mosaicism confers a highly polymorphic gene expression program that allows women to respond with a more expanded immune repertoire as compared with men.


Notwithstanding there is increasing evidence that confirms the sexual dimorphism in certain bacterial infections and the molecular mechanisms associated, further studies are required to clarify conflicting data and to determine the role of specific hormone receptors involved in the gender bias of bacterial infections, as well as their potential as therapeutic targets.



Frequency and severity of infectious diseases clearly vary between men and women. In general, males are more susceptible to diverse bacterial illnesses than their female counterparts [[1]]. This sexual dimorphism is evident throughout all life and starts during the infancy stage, when male predisposition to numerous bacterial infections is evident [[2]]. Variations between male and female individuals in the progression and outcome of infections are intimately linked to genetic, biological, and behavioral differences, which include several factors such as the exposure to certain pathogens, sex steroid hormones, and the development of different immune responses [[3][5]].

In regard to genetic differences, the X chromosome contains several genes implicated in the immune response, such as genes encoding Toll-like receptors (TLR-7 and 8), cytokine receptors, transcription factors, and proteins that participate in the activity of T and B cells [[6], [7]]. During embryonic development, one X chromosome is randomly inactivated in females, but some genes are not silenced, providing women an immune advantage [[3], [8]], who present stronger and more controlled innate and adaptive immune responses than men [[3], [6]].

Sex hormones, besides their multiple roles in reproductive tissues, are able to influence immune cells by modulating their activity in response to infections (Fig. 1). According to the classic mechanism of progesterone (P4), estradiol (E2), and testosterone (T4) action, their cognate receptors progesterone receptor (PR), estrogen receptor (ER), and androgen receptor (AR), respectively, interact with chaperone Hsp90/co-chaperone complexes prior to their binding to hormones. When hormones diffuse into their target cell and interact with their cognate receptor, they induce a conformational change that promotes the dissociation of the chaperone/co-chaperone complex from the hormone receptor with the concomitant receptor dimerization and phosphorylation. Then, the hormone-receptor complex is translocated into the nucleus and binds to specific hormone response elements (HRE) of target genes, which allows the recruiting of co-activators, chromatin remodeling complexes, the basal transcription machinery, and the RNA polymerase II to induce gene expression [[9]].Fig. 1

Sex hormone effects in the expression of inflammatory mediators during bacterial infections. A schematic representation of the classic mechanism of action of progesterone (P4), estradiol (E2), and testosterone (T4) (for details, see the text), as well as the cross-talk with inflammatory signaling during bacterial infections is depicted. When bacterial virulence factors or pathogen-associated molecular patterns (PAMPs) are detected through host pattern recognition receptors such as Toll-like receptors (TLRs), signaling pathways are activated, allowing dissociation of the transcription factor NFκB from its inhibitor IκB, which is subsequently phosphorylated and degraded. Active NFκB is translocated into the nucleus and binds to response elements (NREs) of target genes, allowing the expression of pro-inflammatory genes. In general, P4 induces the expression of anti-inflammatory mediators and probably downregulates the expression of pro-inflammatory factors by sequestering NFκB and inhibiting its activity (indicated by a discontinued line arrow). On the other hand, during early response to infections or sepsis, E2 and T4 display a differential inflammatory effect, in which the former induces the expression of pro-inflammatory mediators by forming a complex with NFκB, and the latter promotes an anti-inflammatory effect. During late response to infections, E2 displays an anti-inflammatory response that prevents systemic damage, while T4 shows a persistent active pro-inflammatory response that triggers systemic damage (not shown). HR steroid hormone receptor, PR progesterone receptor, ER estrogen receptor, AR androgen receptor, HRE hormone response elements

Sex steroid hormone receptors have been identified in diverse cells of the immune system [[3]]. For example, intracellular and membrane-bound ARs have been reported in T and B lymphocytes [[10]], while ERs are present in macrophages, neutrophils, natural killer (NK) cells, and lymphocytes [[11], [12]]. PRs have also been detected in T and B lymphocytes, mast cells, eosinophils, macrophages, and dendritic cells [[13], [14]]. Regarding the effect of sex steroid hormones on the immune system, mediated principally by regulating the NFκB transcription factor activity, testosterone generally functions as a suppressor at early stages of infection, but as an activator during the late response to infection, as it occurs during sepsis; whereas, estradiol acts as an activator, and progesterone functions as an immunosuppressive agent, mainly during pregnancy [[4], [15][17]] (Fig. 1). Therefore, in response to infections, females usually activate Th2 responses and produce high levels of interleukins (IL) IL-4, IL-5, and IL-10 [[14], [18][20]]. On the other hand, males present predominantly Th1 responses and overproduce tumor necrosis factor α (TNF-Uα), IL-1β, IL-2, IL-6, and IL-8, which in turn are frequently associated with inappropriate outcomes such as sepsis and bacteremia [[21][24]]. Besides, women show both higher baseline levels and elevated production of immunoglobulins (Ig) in response to bacterial challenge than men, in particular, IgM [[1], [19]].

Aging and menopause also influence the immune system function, increasing the predisposition to infections [[25]]. During menopause, there is a significant reduction in sex steroid hormone synthesis with a concomitant decrease in immune cell levels and their functional capacity [[1], [25]]. Postmenopausal women and women with induced menopause due to surgical elimination of the ovaries have reduced levels of B cells and anti-inflammatory cytokines, IL-4, and interferon γ (IFNγ), while NK cell activity and levels of pro-inflammatory cytokines such as TNF-α, IL-1β, IL2, and IL-6 are increased [[26][29]]. These effects are partially reversed with hormone replacement therapy [[25], [27]], which corroborates the significant role of sex steroid hormones in the immune system function.

In agreement with the aforementioned studies, development of bacterial infections depends on the influence of gender-associated factors such as sex steroid hormones, through the modulation of differential immune responses between women and men. The aim of the present article is to review the available data in the literature about bacterial infections that present a clear sexual dimorphism, such as gastrointestinal and respiratory infections, and sepsis, among others (Table 1). Although there is increasing evidence that confirms the sexual dimorphism in certain bacterial infections and the molecular mechanisms associated, further studies are required to clarify conflicting data and to determine the role of specific sex hormone receptors in the gender bias of bacterial infections, as well as their role as possible therapeutic targets.Table 1

Gender preference in bacterial infections

Type of infection Gender preference Main bacteria species Associated diseases or complications References
Gastrointestinal tract infections Men Salmonella typhi Typhoid ileal perforation [[30]]
Campylobacter jejuni Inflammatory bowel disease [[37], [38]]
Helicobacter pylori Gastritis, peptic ulcer, and gastric cancer [[39]]
Clostridium difficile Fulminant colitis [[47], [48]]
Yersinia enterocolitica Enteritis, enterocolitis, and gastroenterocolitis [[52]]
Vibrio spp. Gastroenteritis and wound infections [[57], [200], [245], [246]]
Women Enterohemorrhagic Escherichia coli Hemolytic–uremic syndrome and irritable bowel syndrome [[59], [60]]
Respiratory tract infections Men Streptococcus pneumoniae Community-acquired pneumonia [[79]]
Mycobacterium tuberculosis Tuberculosis [[93][100]]
Legionella spp. Legionnaires’ disease [[131], [132], [141], [133][140]]
Bloodstream infections Men Many bacterial species Septic shock, organ dysfunction, severe sepsis [[18], [162], [177], [163], [165][167], [173][176]]
Urinary tract infections Women Escherichia coli Acute cystitis, inflammation, and sepsis [[229], [231]]
Lyme borreliosis Women Borrelia burgdorferi Erythema migrans and facial nerve palsy [[232], [233]]
Sexually transmitted infections Women Chlamydia trachomatis Infertility, ectopic pregnancy, and pelvic inflammatory disease [[235], [237]]
Neisseria gonorrhea Gonorrhea, pelvic inflammatory disease [[234]]
Listeriosis Women Listeria monocytogenes Bacteremia, meningitis [[241]]
Q fever Men Coxiella burnetii Fever, granulomatous hepatitis, myocarditis, pericarditis, and pneumonia [[243]]
Wound infections Men Mycobacterium marinum Swimming-pool granuloma or fish-tank granuloma disease [[245]]

Sexual dimorphism and bacterial infections in the gastrointestinal tract

Certain gastrointestinal infections are more recurrent and severe in men than in women. This sexual dimorphism can be explained in part because of behavioral differences during hygiene and eating practices, such as handwashing before food handling and eating, storage, refrigeration, and defrosting practices, and tendency of men to eat undercooked or raw food, as well as to ingest roadside food [[30]]. Although sexual dimorphism in gastrointestinal infections is mainly due to immune differences, these differences in turn can be influenced by the above mentioned behavioral dissimilarities between women and men. This is the case of typhoid fever and its complication: typhoid ileal perforation (TIP) [[30]]. TIP is characterized by an exacerbated inflammatory activity at Peyer’s patches, probably in response to Salmonella typhi exposure and re-exposure events due to behavioral factors that favors infection in men.

During gastrointestinal injury, males produce predominantly pro-inflammatory cytokines, such as IL-6 and TNF-α, as compared with females whose intestine produce anti-inflammatory factors such as IL-10 as well as protective factors of endothelial function such as a modest rise in nitric oxide (NO) levels [[31]]; in turn, the inflammatory response in males leads to perforation and cell necrosis at the site of infection [[30]]. Sex hormones signaling through their cognate receptors could play an important role in the progression of this pathology and their low incidence in women since both isoforms of ER (ER-α and ER-β) have been identified at Peyer’s patches [[30], [32]], and estradiol induces T cell proliferation and activity, as well as production of anti-inflammatory cytokines [[32]]. The differential concentrations of sex hormones between men and women influence the type of immune response that is activated. Estradiol levels are higher in women (they rise up to 1250 pmol/L during the luteal menstrual phase) than those found in men (37–210 pmol/L), and the mean threshold required to induce production of anti-inflammatory factors and to suppress production of inflammatory cytokines is 690 pmol/L; thus, an inflammatory balanced response is produced in females. On the other hand, testosterone that exhibits higher concentrations in men than in women (6.9–34.7 and 0.7–2.8 nmol/L, respectively), suppresses Th2 response and stimulates Th1 response in males, probably through the activity of ARs located in macrophages and lymphocytes that in turn regulate the differential production of cytokines, which favor the sexual dimorphism observed in this infection [[33][35]]. Additionally, in response to a bacterial stimulus, there is a differential expression of TLRs between females and males, which influences sexual dimorphism of gastrointestinal infections, since females show elevated levels of TLR2 and TLR4 in peritoneal macrophages and in consequence have a higher capacity to detect and eliminate pathogens than males [[36]].

Campylobacteriosis is another gastrointestinal infection that displays a sexual dimorphism [[37]]. This infection of zoonotic origin is caused by Campylobacter jejuni and provokes gastroenteritis, affecting predominantly men, especially young children. C. jejuni infections are related to the development of inflammatory bowel diseases and autoimmune pathologies such as Guillain-Barré syndrome [[37], [38]]. It has been proposed that this tendency is caused by behavioral, environmental, and physiological factors. Strachan and collaborators used a mouse model of infection (Myd88 adaptor protein-deficient mice, which showed persistent colonization by C. jejuni to favor a stable infection), under controlled laboratory conditions that were established to minimize the effects of behavior and environment. They found that bacterial colonization was present in 100% of infected male mice, in contrast to 25% of infected females. Moreover, bacterial counts recovered from feces and different tissues were higher in male than in female rodents, supporting the influence of physiological differences between sexes on the prevalence of this bacterial disease in males [[37]]. However, more epidemiological and experimental studies are required to clarify and/or refuse the role played by environmental and behavioral factors in sexual dimorphism of campylobacteriosis.

In addition, infections caused by Helicobacter pylori affect predominantly males, and its outcomes, such as gastritis, peptic ulcer, and gastric cancer, are also more frequent in males. A possible explanation for this sexual dimorphism is the protective and vigorous immune response exerted by females during H. pylori infections via estrogens (probably through their specific receptors) [[39], [40]]. In this regard, estradiol treatment in males with gastroduodenal preneoplastic alterations reverts the histological modifications such as hyperplasia and dysplasia induced by the carcinogen agent N-methyl-N′-nitro-nitrosoguanidine [[41]]. Moreover, male mice with gastric pathology induced by H. pylori infection have shown reduced expression of pro-inflammatory cytokines IFN-γ and IL-1β, increased expression levels of IL-10 and higher Th2-associated IgG1 responses after estradiol treatments. These findings have been associated with a reduction in the severity of gastric lesions caused by H. pylori [[42]].

Although cancer is not the subject of the present review, it is relevant to mention the protective effect of estrogens in order to explain their role and the ER participation during H. pylori infection to favor a successful outcome in females. It has been demonstrated in gastrointestinal cancer pathologies that cell proliferation pathways are regulated through ER-β. Inhibition of epithelial proliferation has been documented in a cell line of human gastric adenocarcinoma treated with 17β-estradiol [[43]]. Additionally, over-expression of ER-β in ER-β-lacking HCT8 cells (human colon cancer) inhibited cell proliferation by modulating cell cycle regulators such as cyclin E, and producing cell cycle arrest at G1/S phase [[44]]. In another study, ER-β activated by 17β-estradiol also has an inhibitory effect on colorectal cancer tumor proliferation, enhancing DNA mismatch repair by upregulating mRNA and protein levels of MLH1 [[45]], so a similar mechanism could also be involved in female protection against gastric cancer induced by H. pylori infection.

On the other hand, the expression of several H. pylori virulence factors is determined by other gender-specific host characteristics. Blood group antigen binding adhesin A (BabA) of H. pylori is a virulence factor important for bacterial binding to ABO blood group antigens expressed in the gastric epithelium and mucus layer (especially to O/Leb group) and to promote the translocation of CagA oncoprotein by the type IV secretion system into the host cell cytoplasm. Recently, it has been demonstrated that babA expression is elevated in H. pylori-infected male mice as compared with lack of expression in infected females. Additionally, males showed higher bacterial colonization levels than female mice. These findings are independent of adaptive immunity or TLR signaling; thus, other gender-associated factors such as gastric physiology and differential glycosylation patterns of blood antigens can be involved [[46]].

Clostridium difficile infections include diseases ranging from antibiotic-associated diarrhea to fulminant colitis, which are often acquired in hospitals and are associated commonly with men exposed to surgery [[47], [48]]. C. difficile is characterized by forming spores that survive in the acidic environment of the stomach lumen and by producing exotoxins when germination occurs in response to exposure to bile acids in the small bowel [[47]]. The fact that biliary secretions that act as spore germination inductors, such as taurocholate, also known as bile salt, share the fused ring structure with steroid hormones and that both are synthesized from cholesterol has suggested that steroid hormones should also regulate the germination of bacterial spores [[49]]. In this regard, the effects of progesterone and progesterone analogs such as pregnenolone as well as metabolic intermediates of estrogens such as dehydroepiandrosterone (DHEA) have been analyzed on C. difficile spore germination. Some of these steroids inhibit spore germination (progesterone showed a half maximal effective concentration of 80.5 μM and DHEA of 168.3 μM), acting as competitive inhibitors of taurocholate, suggesting an important role of progesterone and estradiol to the resolution of infection caused by C. difficile [[50]].

A sexual dimorphism has also been reported in the disease produced by Yersinia enterocolitica. Yersiniosis is a zoonotic disease transmitted by domestic animals, mainly by pigs, as well as contaminated pork products or water. Y. enterocolitica infection provokes enteritis, enterocolitis, and gastroenterocolitis, which symptoms include bloody diarrhea, fever, abdominal pain, and vomiting; chronic cases of infection develop necrotic enteritis and purulent mesenteric lymphadenitis [[51]]. Yersiniosis is more recurrent in male patients of diverse ages (mainly children) than in females, and this tendency has been reported in an epidemiological study performed in Germany [[52]]. To our knowledge, there are no studies about the gender-associated molecular mechanism involved in the course of infection by Y. enterocolitica; nevertheless, there are higher serum levels of IgG4 antibodies in male patients as compared with female patients in response to Yersinia outer membrane proteins (Yops) [[53]], which are plasmid-encoded virulence factors secreted by a type III secretion system [[51]]; however, researchers did not provide an explanation to this result [[53]]. In the same regard, it has been reported that high levels of IgG4 are related with chronic exposure to antigen [[54]], which in turn is associated to an excessive activation of anti-inflammatory mechanisms that can be related with a resistance to treatment in males as it has been observed in other infections [[55], [56]]. Thus, IgG4 levels in males during Y. enterocolitica infections can be associated with an anti-inflammatory response that interferes with the disease outcome.

Vibrio spp. are marine and estuarine bacteria that cause infections from gastroenteritis to wound infections, also with a higher prevalence in males. The gastric infections by Vibrio spp. are associated with seafood consumption, principally raw oyster ingestion. Vibrio species that commonly causes gastroenteritis are Vibrio parahaemolyticus. V. cholerae, V. hollisae, V. mimicus, and V. fluvialis, infections with a reported male-female incidence ratio of 1.7:1 [[57]]. V. cholerae is the most representative species in the genus, with the highest proportion of cases of Vibrio-associated gastroenteritis (71%), their toxigenic strains belonging to O-group (mainly serogroups O1 and O139) are the cause of epidemic cholera, with 2.86 million cases and 95,000 deaths annually [[57], [58]]. In spite of the evident male prevalence, the molecular mechanism involved in the gender bias in Vibrio infections, particularly the role played by sexual hormones, has not been studied.

In contrast to the aforementioned gastrointestinal infections, enterohemorrhagic Escherichia coli (EHEC) O157 infections are more frequent in female individuals, with 61% of the adult cases from 2000 to 2009 in the Japanese population [[59]]. In another study performed in an Asian population, comparable prevalence rates for females were found since 54.3% cases in Korea and 53.7% in Japan were women [[60]]. A similar pattern was observed during an outbreak of enteroaggregative Shiga-toxin E. coli O104:H4 in Germany in 2011, where most of the infected people were women, corresponding to 58% of infected adults; furthermore, the frequency of women who developed the concomitant hemolytic–uremic syndrome was greater than men [[61]]. Sequels of these infections are also more frequent in female than in male patients, such as irritable bowel syndrome (IBS), a chronic disorder that causes symptoms as cramping, pain, bloating, flatulence, nausea, diarrhea, and constipation [[62], [63]]. In turn, aggravation of IB is associated with alterations of gastrointestinal physiology due to varying levels of sex steroid hormones throughout the menstrual cycle and to the activity of these hormones through their cognate receptors located in the gastrointestinal tract [[64]]. For example, low estradiol during menstruation causes intestinal inflammation by inducing mast cell degranulation and prostaglandin production that in turn are associated with visceral sensitivity and could exacerbate the response to infections [[64], [65]].

In general, sex dimorphism in gastrointestinal infections tends to favor a successful outcome in women, through the actions of estradiol via its intracellular receptors, which, as in other infections, regulate immune system function as well as host non-immune factors and bacterial physiology. In contrast, some infections, such as that caused by EHEC are affected by cyclic changes in female hormone levels, provoking worse outcomes in women. However, differential regulation of immune system in response to specific concentration of female hormones can be an advantage in the treatment of gastric infections.

Bacterial infections in the respiratory tract

In general, males are more susceptible than females to lung diseases such as neonatal respiratory distress syndrome, pulmonary arterial hypertension, idiopathic pulmonary fibrosis, and asthma, and this is also observed for community-acquired and nosocomial bacterial pneumonia, in which severity and higher risk for mortality are associated with male patients [[66][69]]. In fact, it has been suggested that male sex is a frequent risk factor and a predictor of worse outcome for most of the respiratory tract infections, with exception of some upper respiratory tract infections (sinusitis, tonsillitis, and otitis externa) that are more frequently found in females [[67]]. As in other infections, the sexual dimorphism in respiratory infections has also been attributed, independently of sex hormones and genetic factors, to socioeconomic, lifestyle, behavioral, and other factors [[70][72]] that will not be considered in the present review. In women, these differences have been mainly attributed to a gender inequality in work and access to healthcare system [[67]]. Interestingly, it has been reported that there are no significant differences between the immune response of men and women athletes that could be associated with respiratory tract infection incidence, suggesting that in this population there is no sexual dimorphism [[73]].

It has been reported that biological factors could also contribute to the sexual dimorphism observed in respiratory tract infections, such as anatomical and physiological differences in the respiratory tract [[67]]. In women, the higher prevalence of rhinosinusitis could be due to the fact that they have smaller ostia than men, which is more frequently associated with obstruction and therefore with infection [[74]]. In contrast, it has been suggested that the higher prevalence of lower respiratory tract infections in boys during the early years of life is due to peripheral airway width disproportions that are more marked in males [[75]].

The effects of sexual hormones on the immune response of the respiratory tract depend on the experimental model. It has been demonstrated that estradiol induces an increase in inflammatory cytokines (such as TNF-α and IL-6) and chemokines (such as monocyte chemoattractant protein 1 and macrophage inhibitory protein 1α) in the lungs of ovariectomized mice infected with Pseudomonas aeruginosa, which in turn is associated with a neutrophil dysfunction and a worst outcome as compared with vehicle-treated female mice and intact males. Interestingly, this effect was ER dependent [[76]]. In contrast, in an experimental model of pleurisy (pleural inflammation) in ovariectomized rats, estradiol treatment prior to the inflammatory insult was associated with a decrease in NO production, migration of polymorphonuclear cells, and tissue injury, which was also ER dependent [[77]]. Furthermore, it has been suggested that estradiol promotes an increase of IgA transport into the mucosa of the respiratory tract protecting against pneumonia [[78]]. More studies are required to elucidate the beneficial or detrimental effects of estradiol and other sexual hormones during respiratory tract inflammation.

The incidence of community-acquired pneumonia is higher in men than in women, and this incidence increases by age, especially in infections with Streptococcus pneumoniae, Streptococcus pyogenes, Chlamydophila pneumonia, and Legionella pneumophila [[79][86]]. On the other hand, a gender preference for pneumonia caused by drug-resistant pathogens such as P. aeruginosa, extended-spectrum-beta-lactamase-positive Enterobacteriaceae, and methicillin-resistant Staphylococcus aureus has not been established, as this gender preference depends on the studied population [[87][89]]. Females have a 57% reduced risk to acquire ventilator-associated pneumonia after mechanical ventilation, which has been reported to affect 72.7% of males, mainly due to Gram-negative bacterial infections [[90], [91]]. In contrast, women under the age of 50 years are more susceptible to respiratory infections by Mycoplasma pneumoniae [[92]]. For a comprehensive and complete review of the incidence and severity in respiratory tract infections refer to [[67]].

Tuberculosis, caused by Mycobacterium tuberculosis, is one of the most studied models regarding sexual dimorphism in respiratory tract infections. In humans, tuberculosis is one of the leading causes of death from infectious diseases. It was diagnosed in about 8.6 million people in 2012, and it has been predicted that one third of the population in the world has a latent infection [[93]]. Some of the risk factors for tuberculosis infection are malnutrition, smoking, diabetes, and sex [[94]]. Although the prevalence of tuberculosis in males depends on the geographic region, there is a general trend for the male-to-female ratio affecting more males with poorer outcome in developing countries, including a higher risk of mortality [[93], [95][100]]. This male gender prevalence is also observed when combining other risk factors such as human immunodeficiency virus (HIV) infection, diabetes mellitus, and smoking [[101][104]]. It has been reported that Bacillus Calmette-Guerin (BCG) unvaccinated males display a stronger IFN-γ response against the tuberculin purified protein derivative (PPD) than females, which suggests that males display a stronger immune response that could be associated with an uncontrolled inflammatory response and a poor prognosis during M. tuberculosis infection [[105]]. During tuberculosis infection, there is also a differential immune response characterized by females showing higher levels of the C-X-C Motif Chemokine Ligand 9 (CXCL9) and males showing higher levels of the Platelet Derived Growth Factor Subunit B (PDGFB), serum C-reactive protein, and specific antibodies against M. tuberculosis than their gender counterpart, highlighting a stronger innate and humoral immune response in males [[106], [107]]. Furthermore, the plasmatic levels of the anti-tuberculosis drugs, isoniazid, and pyrazinamide are lower in adult males than in females. This could be related to the worst outcome in the treated males [[108]]. Interestingly, this higher proportion of affected males is not observed in children or young adolescents, suggesting the participation of sex hormones in the pathogenesis of tuberculosis [[109], [110]]. In line with this, it has been reported that the prevalence of tuberculosis associated deaths in a mentally retarded population was lower in medically castrated males (8.1%) compared with intact males (20.6%) and females (15.8%) [[111]]. Women who underwent medical oophorectomy present an increased risk of mortality because of tuberculosis [[112]]. However, it has been also demonstrated that this male bias to tuberculosis infection is due to genetic factors, illustrated by X-linked TLR8 gene polymorphisms that have been associated with increased susceptibility to tuberculosis in male children [[113]], as well as by the X-linked Mendelian susceptibility to mycobacterial diseases due to mutations in IKBKG and CYBB genes, that participate in the induction of IL-12 by mononuclear cells and the activation of the respiratory burst in macrophages, respectively [[114]]. Besides, it has been reported that elderly women with decreased estrogen levels (postmenopausal women) have an increased risk of chronic lung infections produced by nontuberculous Mycobacterium infections [[115]]. Particularly, it has been found that decreased DHEA (an endogenous intermediate in the conversion of cholesterol to estrogens and androgens) levels in elderly women are associated with M. avium complex infection, a nontuberculous mycobacterial lung infection [[116]]. These studies suggest that nontuberculous Mycobacterium infections are also influenced by hormones, which in turn explains the sexual dimorphism in overall Mycobacterium infections in the respiratory tract.

Animal models have been used to further investigate the role of sex hormones in the pathophysiology of tuberculosis. Early studies demonstrated that male mice are more susceptible than female mice to infection with M. intracellulare and M. marinum and that testosterone treatment increases female and castrated male mice susceptibility to M. marinum showing more severe granulomatous lung lesions, contrary to the protective effect observed after estradiol treatment in ovariectomized mice exposed to M. avium [[117][119]]. Sex bias has also been reported in M. tuberculosis mice infection, where male mice are at greater risk of mortality and show higher numbers of bacilli burdens in lungs with a lower pro-inflammatory response (constituted mainly by decreased levels of lymphocytes, macrophages, and expression of pro-inflammatory cytokines) than female mice and castrated mice [[120]]. Interestingly, it has been demonstrated that medroxyprogesterone acetate (DMPA), a progestin commonly used as a contraceptive, decreases the cytokine response to M. tuberculosis in C57BL/6 and BALB/c mice [[121]].

Regarding other animal models, it has been reported that bovine tuberculosis caused by M. bovis also displays a worse outcome, higher mortality rate, and more rapid progression rates in males than in females, and this difference has been attributed to an immunosuppression induced by testosterone in males [[122][124]]. The above studies clearly demonstrate a sexual dimorphism in Mycobacterium spp. respiratory tract infections affecting more males than females, which is influenced by estradiol and testosterone and the genetic background. The participation of sex hormone receptors in this dimorphism has not been elucidated.

In the natural model of murine respiratory mycoplasmosis induced by M. pulmonis, it has been demonstrated that male mice display a more severe clinical outcome than females, with higher rates of mortality and worse signs of alveolar disease, but in contrast to other mycoplasmosis, the removal of gonads decreases the severity of lung injury and bacilli number in both sexes [[125]]. Interestingly, in this study, sex differences in M. pulmonis infection were remarkable since male mice showed an acute alveolar inflammatory response (edema, hemorrhage, and neutrophil infiltrate) whereas female mice showed a chronic peribronchial inflammatory response (macrophage and few neutrophil infiltrates), which explains the worse outcome in males [[125]].

Legionnaires’ disease is a severe form of infection with Legionella species, which are Gram-negative bacteria that are ubiquitously found in natural and artificial aquatic habitats, as well as in moist soil and mud [[126], [127]]. Legionellosis is mainly characterized by pneumonia with a high incidence of mortality rates, and although it is frequently observed as sporadic cases, it has been also reported in community and hospital outbreaks mainly due to contamination in the air conditioning systems [[128][130]]. It has been reported a strong association of legionellosis with male gender in many European, American, and Asian countries, as well as in Australia, and in fact, male gender is considered as a poor prognostic factor [[131][141]].

In contrast to the mentioned respiratory tract infections, there are bacterial infections that affect more females than males. These gender differences have been clearly demonstrated in cystic fibrosis disease (CF) that is characterized by a dysregulated inflammatory response and an altered cytokine profile in the lungs that is associated with a higher prevalence of bacterial infections (mainly due to P. aeruginosa) and poorer lung and respiratory muscle function in females than in males [[142][144]]. Differential estradiol levels between females and males have been proposed as a factor that explains the sexual dimorphism in CF-associated infections because differences in gender lung function are observed after puberty and are correlated with estrogen levels during the menstrual cycle [[145]]. In particular, high estradiol levels in CF females have been associated with the conversion of P. aeruginosa in a highly pathogenic mucoid bacteria that induces parenchymal damage in the lung [[146]]. Moreover, the increase in estradiol levels in CF females upregulates the expression of the secretory leucoprotease inhibitor via ER-β, that in turn inhibits the TLR-dependent IL-8 release in CF bronchial epithelial cells predisposing to P. aeruginosa infection and colonization [[147]]. It has been demonstrated that P. aeruginosa pulmonary infection is also associated with a worse outcome in female mice, which is characterized by a more pronounced weight loss, higher numbers in bacterial load, and a higher inflammatory response than those observed in male mice [[148]]. It has been also reported that female sex is associated with an increase in the mortality rate in a model of CF mice with P. aeruginosa pulmonary infection [[149]]. Furthermore, estradiol administration increases the severity of P. aeruginosa pneumonia in adult CF male mice by upregulating IL-17 signaling and promoting lung tissue damage [[150]].

Interestingly, it has been reported that perinatal pulmonary infection induced by the intracellular bacteria Chlamydia muridarum displays a sexual dimorphism in terms of hippocampal expression of corticosteroid receptors associated with an altered stress response that emerges during adulthood, in which females are more affected by neonatal infection than males as demonstrated by an increase in glucocorticoid receptor and tyrosine hydroxylase content in adulthood, that in turn leads to a dysregulation of the hypothalamic–pituitary–adrenal axis [[151]]. This highlights the importance of the sexual dimorphism in bacterial infections not only in the affected tissue but also in other organs such as the brain.

There are epidemiological studies reporting that air pollution confers a higher susceptibility to respiratory tract diseases to females as compared with males [[152][154]]. Although there are some controversies about this prevalence in humans, studies in mice have demonstrated that after ozone-induced oxidative stress, there is a decrease in survival rate that is more pronounced in female than in male mice in Klebsiella pneumoniae lung infection, which is in contrast to the lower survival rate observed in male mice in ozone-free conditions. These differences have been associated with a compromised spleen, reduction in functional activity of surfactant protein A, increased plasma cortisol levels, and reduced phagocytic ability of alveolar macrophages in ozone-exposed female mice [[155][157]]. Ozone exposure alone is associated with an increased inflammatory response, higher lung vascular permeability, and higher number of polymorphonuclear neutrophils in bronchoalveolar lavage in female mice [[158]]. Interestingly, it has been proposed that female gonadal hormones (estradiol and progesterone) are protective against K. pneumoniae pulmonary infection; however, the protective effect is lost after ozone exposure, and even leads to a worse outcome that could be related to the excessive activation of the inflammatory pathway in response to estradiol and ozone exposure [[159]].

Although there is an evident sexual dimorphism in both humans and animal models of respiratory tract infections, the participation of hormone receptors has been poorly explored. The fact that estradiol and testosterone have been proposed to participate in the pathogenesis of the mentioned respiratory tract infections strongly suggests that intracellular and/or membrane hormone receptors are involved in this sexual dimorphism. One example is the participation of ER-β in the inhibition of TLR dependent IL-8 release in CF bronchial epithelial cells in the model of CF mice infected with P. aeruginosa, which clearly demonstrates an important role of hormone receptors in the gender bias of P. aeruginosa induced pneumonia [[147]]. Therefore, further studies are required to elucidate the participation of hormone receptors in the sexual dimorphism observed in bacterial infections in the respiratory tract that in turn could help in prognosis and management.

Sexual dimorphism and bacterial sepsis


The host response against a bacterial infection that leads to a systemic inflammatory response syndrome is defined as sepsis, which is characterized by the increase in TNF-α, IL-1β, IL-6, and IL-8 cytokine secretion mainly by macrophages after the recognition of bacteria or bacterial-derived lipopolysaccharide (LPS) via TLRs [[21], [160]]. Although there are some controversies about the sex-specific response in sepsis patients [[161]], it has been stated that gender plays a significant role in post-injury pathogenesis and its association with the susceptibility to sepsis by affecting more males than females [[162], [163]]. This gender bias is explained only in part because of occupational, hygiene, and sport activities differences among men and women [[164]]. In fact, male gender is considered as one of the four risk factors associated with the development of sepsis in general surgical and post-traumatic patients, with a hospital mortality rate of 70% in male and 26% in female patients [[18], [165], [166]]. Moreover, it has been reported that male gender along with HIV infection is a risk factor for bacteremia, suggesting an important role of immune suppression [[167]]. The pathological response to trauma-hemorrhage in rodent males, ovariectomized females, and testosterone-treated females is characterized by a severe suppression of the immune response and multiple organ dysfunctions, leading to a high incidence of sepsis [[168][170]]. Interestingly, these effects are not observed in proestrus rats, estradiol-treated ovariectomized rodents, castrated male rodents, and estrogen-treated males, which clearly point out the participation of estradiol and testosterone in the sex bias of sepsis after trauma-hemorrhage [[168], [171], [172]].

Moreover, a differential immune response between genders during sepsis has been observed and is characterized by a specific profile of pro- and anti-inflammatory cytokines. In particular, male patients display higher levels of pro-inflammatory cytokines such as IL-6 and TNF-α as well as increased levels of bacteremia markers like procalcitonin in sepsis than females [[173][176]]. In contrast, female patients display higher levels of the anti-inflammatory cytokine IL-10 than males [[18]]. These differences between immune responses before and after trauma-hemorrhage leading to sepsis suggest that females display an early and controlled pro-inflammatory response that prevents infection which is followed by an anti-inflammatory response that avoids systemic damage, while males display a late and persistent active pro-inflammatory response leading to systemic damage. Besides, the fact that sexual dimorphism in severe sepsis is also observed in prepubertal children and elderly people suggests that genetic and environmental factors are also involved in this gender bias [[177][179]].

Experimental sepsis

Animal models have been widely used to study sex differences in regard to immune response and clinical effects of sepsis. In particular, cecal ligation and puncture (CLP) in mice, leading to polymicrobial sepsis, has demonstrated that proestrus female mice display a higher survival rate than male mice, along with a marked increase in splenocyte proliferation and IL-2/IL-3 release as compared with male mice, suggesting that immune homeostasis regulation is better regulated in females than in males [[180]]. Remarkably, beta-glucan therapy promotes survival in mice subjected to CLP and displays a better protective effect in female than in male mice by enhancing bacterial clearance, which is dependent on sex hormones [[181]]. The use of estradiol or DHEA in male mice subjected to CLP improves splenocyte, macrophage, and T cell activity [[182], [183]]. Sex differences favoring female mice after CLP are similar to the better prognosis observed in female patients undergoing major abdominal surgery; in these cases, male patients present decreased numbers of circulating B and T lymphocytes and NK cells after abdominal surgical intervention [[184]]. It has been proposed that sex differences in prognosis after abdominal trauma and subsequent sepsis are due to an enhanced and strictly regulated antimicrobial host defense in the female peritoneum as compared with that of males, which in females, is characterized by a higher number of quiescent leukocytes (mainly T and B lymphocytes), competent resident macrophages (that highly express TLRs and display elevated phagocytosis), and immunomodulatory CD4 lymphocytes [[11], [36]]. Furthermore, estradiol and progesterone are necessary to maintain homeostasis regulation of resident leukocytes in the female peritoneum, while testosterone disrupts the trigger of an appropriate innate immune response against polymicrobial insult [[36], [185]].

Another sepsis model in animals is the “two-hit” model that consists in trauma-hemorrhage-induced shock (first hit) and subsequent sepsis (second hit), in which females display a better outcome and survival than males, presenting lower plasma levels of pro-inflammatory markers (IL-6, TNF-α, and prostaglandin E(2)) after sepsis [[186]]. However, a recent study failed to find a correlation between inflammatory markers and the different outcome observed in female and male mice in the “two-hit” model [[187]]. A protective effect has been observed in proestrus rat during hemorrhagic shock as compared with other estrous cycle phases; this has been attributed to the highest levels of estradiol in proestrus phase [[188]]. Protective effects of estradiol against sepsis following hemorrhagic shock have been reported in trauma-hemorrhage-induced lung and hepatic injury by decreasing the TLR4-dependent release of pro-inflammatory cytokines (IL-6, TNF-α, and macrophage inflammatory proteins 1α and 2) and chemokines (monocyte chemoattractant protein-1 and keratinocyte-derived chemokine), as well as the induction of the inducible nitric oxide synthase (iNOS) expression, neutrophil influx, and tissue damage [[189][191]]. On the other hand, higher levels of testosterone and its derivatives (such as 5α-dihydrotestosterone, DHT) are associated with negative effects during trauma-hemorrhage that are associated to immunosuppression and subsequent sepsis in mice. In particular, DHT has been implicated in the decrease of splenocyte proliferation; macrophage function; decline of IL-1, IL-2, IL-3, IL-6, and IFN-γ release by splenocytes and peritoneal macrophages; and a marked increase of IL-10 levels [[170], [192], [193]]. In addition, it has been reported that testosterone downregulates the expression of the major histocompatibility complex (MHC) class II receptor on splenic and peritoneal macrophages after trauma-hemorrhage, reinforcing immune suppression [[194]]. The role of testosterone in the suppression of the immune system in the sepsis model has been confirmed by using the antagonist of the AR, flutamide that in turn improves survival and organ function in male mice [[195], [196]].

In vitro studies have shown that after LPS exposure, TNF-α levels are lower in peripheral blood cells isolated from premenopausal women than those from men and postmenopausal women; however, this was not associated to estradiol or testosterone levels in premenopausal women [[197]]. In addition, it has been reported that estradiol and LPS treatments in peripheral blood mononuclear cells isolated from women and men healthy volunteers induce the secretion of TNF-α and IL-6, while estradiol and LPS treatments decrease IL-10 secretion only in male sepsis patients, which suggests that the worst prognosis in males after sepsis is associated with a non-regulated immune response [[198]]. More studies are required in order to elucidate the role of IL-10 in sepsis affecting males since the increased levels of this cytokine are associated with a worse outcome by exerting suppression in the immune response, whereas its reduction leads to a non-controlled pro-inflammatory response. Interestingly, both effects are dependent on sex hormones.

One of the most used models to simulate bacteremia is LPS injection into bloodstream, which is known as experimental endotoxemia. Although there are controversies about the mechanisms involved in the sexual dimorphism of LPS response, it is accepted that males are more affected than females in LPS-induced endotoxemia [[199], [200]]. It has been reported in mice and rat models that males and ovariectomized females show higher levels of IL-6- and LPS-binding protein (LBP, that promotes a pro-inflammatory cellular response) after LPS-induced endotoxemia [[20], [201]]. An increase in visfatin expression levels (an adipokine with pro-inflammatory properties) has been reported in the serum, liver, and adipose tissue from male and female rats after LPS-induced endotoxemia, and this increase is higher in the adipose tissue of ovariectomized rats that also display a worse outcome and higher levels of mortality than intact animals [[202], [203]]. In contrast, it has been reported that male rats display an early suppressive immune response (decreased levels of TNF-α as compared with females) after LPS injection that is testosterone dependent, confirming an increased susceptibility to sepsis in males as compared with females [[204]]. Furthermore, an acute pro-inflammatory response characterized by a higher increase in TNF-α levels in female than in male calves was observed after LPS treatment, which was associated to a better outcome in females [[205]]. In line with this, women show a higher pro-inflammatory innate immune response during experimental endotoxemia than men, as revealed by a higher leukocyte sequestration, greater levels of the pro-inflammatory cytokine TNF-α, and increased levels of the LBP without changes in the anti-inflammatory cytokine IL-10 [[206]]. Further studies are required to overcome controversies in the elucidation of the molecular differences involved in gender bias after LPS-induced endotoxemia.

Although a marked sexual dimorphism in favor of females is observed in the development of sepsis, it has been proposed that in some cases females display a higher risk than males to severe shock once sepsis has occurred. This is the case of the superantigen toxic shock affecting more women than men, which has been associated with menstrual infections [[207]]. Superantigens are known as potent T cell activators that bind to the class II MHC and T cell receptors [[208]]. Therefore, a toxic shock is produced by the superantigen-induced T cell hyperactivation that leads to an increase of plasma pro-inflammatory cytokines (IL-1, TNF-α, TNF-β, and IFN-γ), profound hypotension, and multiorgan failure [[208][210]]. Despite the fact that superantigen toxic shock gender bias could be explained by its relation to menstrual-associated infections, it has also been demonstrated that female mice are more sensitive than males to superantigen-mediated toxic shock, which is associated with an ER-dependent increase in plasma TNF-α levels, liver damage, and lower survival in female mice, confirming the role of sex hormones in sexual differences of superantigen toxic shock [[211]]. This is also true for animal models in which the gender bias is influenced by the specific model of study and bacteria. In particular, estradiol administration prevents bacteremia in ovariectomized rats intraperitoneally inoculated with Enterococcus faecalis by increasing TNF-α and NO levels [[212]]. Male mice are more susceptible to Streptococcus pneumoniae intravenous administration than females by showing higher mortality rate, weight loss, and body temperature decrease, along with an increase in blood pro-inflammatory cytokines such as IL-6, IL-17A, RANTES, and IFN-γ as compared with female mice [[81]]. On the other hand, Listeria monocytogenes systemic infection is more prevalent in female mice due to the estrogen downregulation of IFN-γ and IL-10 induction that leads to an immune suppression [[213]].

Genetic-dependent effects

Interestingly, it has been demonstrated that female X chromosome mosaicism (due to X random inactivation) provides an expanded repertoire of immune functions in females as compared with males [[214]]. Since a large number of genes related to immune functions are located on the X chromosome, X-linked mosaicism confers a highly polymorphic gene expression program that is specific to different cell subpopulations which respond differently to particular immune challenges [[215]]. It has been reported that mosaic mice with a heterozygous deficiency of the X-linked Nox2 gene (that encodes the catalytic subunit of the NADPH oxidase complex in phagocytes) displays a clear advantage during CLP as compared with wild-type animals, which is characterized by lower plasma IL-6 levels, reduced oxidative stress, higher bacterial clearance and improved survival, highlighting the contribution of genetic factors in the sexual dimorphism during sepsis [[214]]. This finding was further confirmed in a similar model with a heterozygous deficiency of the X-linked Irak1 gene (involved in the activation of the innate immune response) that displays better survival, lower plasma IL-6 and IL-10 levels, and non-altered splenic B and T cell populations as compared with wild-type animals in a CLP model [[216]]. Furthermore, it has been reported that mesenchymal stem cells obtained from female mice display a greater protective effect of myocardial function than those derived from male mice in a model of endotoxemia, confirming that genetic factors are also responsible for the gender bias in sepsis [[217]].

It has been suggested that a dimorphic expression of TLR4 is associated with a differential immune response between males and females [[218]]. In particular, higher levels of TLR4 expression in macrophages from male mice have been associated with a damaging and uncontrolled pro-inflammatory response following endotoxic shock induced by LPS administration [[20]]. More studies are required to demonstrate the sexual dimorphism in TLR4 expression since another study failed to find this differential expression between macrophages from male and female mice [[219]]. Although there is a clear prevalence of sepsis in males, sexual dimorphism does not always favor females since it depends on the population evaluated as well as on the bacterial species (Table 2). Interestingly, the differences in gender susceptibility to bacteremia among different populations highlight the importance of genetic background in the sexual dimorphism and sepsis.Table 2

Gender preference in sepsis induced by specific bacterial species

Bacteria species Gender preference Population References
Staphylococcus aureus Women Israel [[250]]
Men United States of America [[251]]
Staphylococcus aureus (methicillin resistant) Women Brazil [[252]]
No differences United Kingdom [[253]]
Women United States of America (hemodialysis patients) [[254]]
Men Australia, Sweden, Denmark, Germany, Spain, United Kingdom, United States of America [[255][258]]
Salmonella enterica (non-typhoidal) Men Six regions in Finland, Australia, Denmark, and Canada [[259]]
Escherichia coli (extended-spectrum β-lactamase-producing) Women Cancer patients [[260]]
Escherichia coli Women Denmark [[261]]
Klebsiella spp. Men Denmark [[262]]
Streptococcus milleri Men Canada [[263]]
Streptococcus spp. Men United States of America [[251]]
Aeromonas spp. Men Spain (chronic liver disease or neoplasm) [[264]]

Estrogen and androgen receptor-dependent effects

The fact that sex hormones participate in the gender bias observed in sepsis strongly suggests the participation of their receptors during this process, particularly ERs [[220]]. It has been demonstrated that treatment with specific ER-α and ER-β agonists, propyl pyrazole triol (PPT), and diarylpropiolnitrile (DPN), respectively, induce protective effects on intestinal microcirculation in both male and ovariectomized rats during sepsis, providing a plausible explanation of homeostasis regulation of resident leukocytes in the female peritoneum [[221]]. Interestingly, it has been reported that after trauma-hemorrhage, PPT inhibits the TNF-α and IL-6 release by Kupffer cells and promotes their production in splenic macrophages probably by the MAPK signaling pathway, while DPN has the same effect on alveolar macrophages and peripheral blood mononuclear cells. In addition, IL-10 secretion was decreased by PPT on Kupffer cells and by DPN on peripheral blood mononuclear cells, suggesting a differential role of ER-α and ER-β in the protective effect of estradiol after trauma-hemorrhage that also depends on the specific tissue compartment [[222][224]]. Furthermore, PPT administration prevents the splenic T cell suppression observed after trauma-hemorrhage by enhancing IL-2 and IFN-γ secretion via MAPK, NF-κB, and AP-1 signaling pathways, while it inhibits NF-κB and AP-1 signaling pathways on Kupffer cells to decrease iNOS expression and prevent hepatic damage [[225], [226]]. On the other hand, treatments with the ER-β selective agonist, WAY-202196, exert a protective effect in both male and female rodents subjected to CLP by decreasing TNF-α and IL-6 levels, reducing bacteremia, and maintaining intestinal integrity [[227]]. It has been recently reported that raloxifene, a selective ER modulator, reduces the effects of LPS-induced endotoxemia in ovariectomized rats via the induction of antioxidant and anti-inflammatory proteins such as heme oxygenase 1 (HO-1) and heat shock protein 70 (HSP70), respectively [[203]]. Further studies are required to elucidate the participation of other sex hormone receptors by using specific agonists and antagonists, such as in the case of flutamide, an AR antagonist that displays protective effects in sepsis models, as previously mentioned [[228]]. Moreover, the role of PRs during sepsis has not been assessed. The study of the participation of both membrane and intracellular hormone receptors would provide an extensive repertoire of pharmacological treatments to prevent or manage sepsis.

Other bacterial diseases

Among other diseases that display a sex-based predominance are urinary tract infections (UTIs), which are present in females more often than in males [[229]]. UTIs in women occur more frequently than in men due to anatomical and physiological differences; for example, the urethra is shorter than that of men, and the distance between the anus and urethral meatus is also shorter in women. Additionally, the perimeatal region has less humidity in men than in women and prostatic secretions show antibacterial activity [[230]]; therefore, the probability of bacterial colonization and development of infection is lower in men. Seventy percent of these infections are related to E. coli strains. It has been reported that 65% of hospitalized elderly patients with UTI that have developed sepsis are women, similarly to the 54.8% of cases with a fatal outcome that has been documented in women [[229]]. Menopause is one of the risk factors of UTIs mainly due to the reduction of sex hormone levels, predominantly estrogens. When estrogen levels are low, as in postmenopausal woman, urogenital colonization of lactobacilli is decreased, which in turn produce a pH rise that allows the growth of Enterobacteriaceae, particularly E. coli [[231]].

Lyme borreliosis, a vector-borne inflammatory disease produced by Borrelia burgdorferi, is more common in women in the European population, frequently older than 44 years with recurrent infection and previously diagnosed with erythema migrans, the cutaneous manifestation of the infection. In contrast with men, women show an increased secretion of cytokines IFN-γ, IL-4, IL-6, IL-10, and TNF-α. In addition, elevated ratios of IL-10/TNFα and IL-4/IFN-γ have been observed in postmenopausal women, suggesting increased anti-inflammatory and Th2-based immune responses, while pro-inflammatory activity is reduced, which could explain the prevalence and recurrence of B. burgdorferi in this population [[232]]. Neurological form of disease, Lyme neuroborreliosis, is also common in female patients, mainly in girls, who usually present facial nerve palsy; in contrast, it is suggested that boys have a stronger immune response than girls during B. burgdorferi infection since boys have a higher level of cerebrospinal fluid inflammation (pleocytosis) [[233]]. It is suggested that during infancy males have a stronger innate immunity compared with females, presenting higher counts of basophils, monocytes, NKs, and higher levels of inflammatory mediators than females, as it has been reported after stimulation with LPS or mitogens [[33]]. Contradictory findings in Lyme borreliosis also can be related with differences in sex hormonal levels between women and men, children and adults, and variations through menstrual cycle and menopause, which can differentially influence the immune system function.

Sexually transmitted infections also have female predominance; as it is the case of infections of the genital tract caused by Chlamydia trachomatis and Neisseria gonorrhoeae. Susceptibility to both diseases is related to estradiol and progesterone levels, which throughout the menstrual cycle regulate the differential recruitment and function of immune cells and other components of the immune system [[25], [234], [235]]. An example of the influence of estrogens in C. trachomatis infection is observed when infected HeLa cells are treated with 17-β-estradiol or with diethylstilbesterol (a synthetic estrogen analog), enhancing the adherence, growth, and elementary body formation of this bacterium [[236]]. Moreover, β-estradiol levels present an inverse correlation with the cervical concentration of cytokines IL-1β, IL-6 and IL-10 during primary chlamydial infections. Progesterone also presents a negative correlation with IL-1β in women with recurrent infections [[237]]. High estrogen levels also influence the susceptibility of females to gonococcal infection since N. gonorrhoeae-infected mice treated with 17β-estradiol developed bacteremia quickly, due to the effect of estradiol on the levels and function of polymorphonuclear leukocytes, that become unable to eliminate gonococci [[238]]. Besides, high levels of progesterone, such as those observed during the luteal phase of the menstrual cycle, also promote gonococcal infection in human cervical epithelial cells through the increase of Akt kinase activity, which in turn increases NOS expression and NO production, favoring the N. gonorrhoeae survival and replication [[239]].

Listeria monocytogenes infection is a disease acquired by contaminated food ingestion; however, the infection reaches the spleen, the liver, and the bloodstream causing bacteremia and, in some cases, reaches the brain producing meningitis [[240]]. Listeriosis predominantly affects females, and it has been mainly attributed to increased levels of IL-10, which has been observed in infected female mice that also show elevated bacterial counts in the liver and spleen, as well as higher rates of mortality than males. IL-10 acts as an immunosuppressor, by inhibiting Th1 differentiation and synthesis of Th1 cytokines, as well as by suppressing macrophage effector function, antigen presentation, and proliferation of T cells. On the contrary, infected male mice have elevated levels of IFN-γ that helps to the resolution of disease, contributing to male-resistance to Listeriosis [[241]]. It has been observed that estrogen action influences female predisposition to Listeriosis by modulating the immune response to infection. When Listeria-infected mice are treated with β-estradiol, there is a reduction of monocytes and leukocytes at the infection site, and cells obtained from peritoneal exudates have an increased expression of IL-4, IL-10, and transforming growth factor-β (TGF-β), while IFN-γ, IL-12, and TNF-α expression is decreased, which in turn is related to a suppression of bactericidal activity and to a shift of Th1 to Th2-response [[242]].

On the contrary, infection produced by Coxiella burnetii, known as Q fever, is a disease that preponderantly affects males. Patients with Q fever present diverse symptoms such as fever, granulomatous hepatitis, myocarditis, pericarditis, and pneumonia, which occur more frequently in men. Ovariectomized mice infected with C. burnetti and treated with 17β-estradiol display reduced spleen bacterial load and granuloma, suggesting that sexual dimorphism in C. burnetti infection is linked to sex hormones action [[243]]. Variations in the infection with C. burnetti between male and female mice are associated with differential gene expression programs. For example, in male mice, an upregulation of IL-10 and IFN-γ genes has been observed, while genes that encode defensins were downregulated, increasing bacterial proliferation. On the other hand, in female mice, there are changes in the regulation of genes involved in circadian rhythm, that are related to estrogens secretion and IFN-γ production, which in turn are possibly associated with the successful control of infection [[244]].

Wound infections caused by marine bacteria also display male predominance, such as the case of M. marinum, an aquatic bacterium that produces the swimming-pool granuloma or fish-tank granuloma disease, which progresses in necrotizing lesions that in some cases reaches tendons and bones [[245]]. Marine bacteria of Vibrio genera that produce infections in skin lesions are represented by V. vulnificus, V. alginolyticus, V. parahaemolyticus, and non-O1 V. cholerae. Wound infections by Vibrio spp. mainly occur in men over 50 years of age with a preexisting lesion that is exposed to contaminated seawater or seafood, developing edema, cellulitis, vesicles, and necrosis [[245], [246]]. The low frequency of these infections in women has been associated with a protective role of estrogens against the endotoxins of V. vulnificus [[200], [245]].

Also, periodontal infections show sexual dimorphism, for instance, men are more susceptible than women to develop periodontitis, which as other infections are mainly attributed to the elevated production of pro-inflammatory cytokines in response to differential gene regulation through the action of sex steroid hormones [[247]]. In this respect, Cotti and others found that patients with endodontic infection (apical periodontitis) have increased levels of cytokine IL-2; however, these levels are considerably more elevated in men than in women [[248]]. In addition to IL-2, male patients present elevated levels of other inflammatory markers such as IL-1, IL-6, and asymmetrical dimethylarginine (ADMA, the inhibitor of NOS), as well as IgA, IgG, and IgM [[248], [249]]. Interestingly, chronic periodontal inflammation is considered a cause of endothelial dysfunction by inducing reactive oxygen species production in response to NO synthesis inhibition by ADMA, that in turn contributes to the development of cardiovascular diseases, which are more frequent in men than in women [[248]].

As it has been exposed in other sections of this review, gender prevalence in diverse bacterial infections is mainly associated to differential sex-linked immune responses regulated by sex hormones. However, host metabolic pathways, as well as expression and activity of bacterial virulence factors, are also affected by hormone action, which can influence the development of adverse sequels of infections that also show gender-associated predominance (Table 1).


Sexual dimorphism in bacterial infections is attributed to socioeconomic, lifestyle, behavioral, and biological factors. The latter was reviewed in the present study and is represented by genetic factors and sex steroid hormone levels and their actions in the host, as well as by the specific bacterial species that produce infection. In general, males are more susceptible to gastrointestinal and respiratory bacterial diseases and sepsis, while females are more susceptible to urinary tract bacterial infections; however, there are conflicting data regarding other specific bacterial diseases. Sexual dimorphism is in part explained by the pro-inflammatory properties of estradiol and by the anti-inflammatory effects of testosterone via the interaction with their specific intracellular receptors. However, the participation of other hormone receptors such as PR and other membrane or intracellular receptors in the gender bias of bacterial infections has not been elucidated. Interestingly, female X chromosome mosaicism provides an advantage to females due to the expanded repertoire of immune functions. Further studies are required to clarify contradictory data and to elucidate the molecular pathways of sex steroid hormone actions involved in the gender bias of bacterial infections in order to use sex hormones, their synthesis pathways, and their receptors as possible host-directed therapeutic targets.



EGG thanks CONACYT for the assigned Cathedra (project 899). The authors acknowledge Dra. Norma Espinosa Sánchez for critical comments on the manuscript.


Work in our groups is supported by grants from Dirección General de Asuntos del Personal Académico, UNAM (IN209617) to B. González-Pedrajo and from Programa de Apoyo a la Investigación y al Posgrado, Facultad de Química, UNAM (5000-9107) to I. Camacho-Arroyo.


  1. JA RettewI MarriotYM HuettSL KleinCW RobertsSex differences in innate immune responses to bacterial pathogensSex hormones and immunity to infection2010BerlinSpringer123146
  2. M MuenchhoffPJ GoulderSex differences in pediatric infectious diseasesJ Infect Dis2014209SupplS120S12610.1093/infdis/jiu23224966192
  3. G GhazeeriL AbdullahO AbbasImmunological differences in women compared with men: overview and contributing factorsAm J Reprod Immunol20116616316910.1111/j.1600-0897.2011.01052.x21749547
  4. E Garcia-GomezB Gonzalez-PedrajoI Camacho-ArroyoRole of sex steroid hormones in bacterial-host interactionsBiomed Res Int2013201392829010.1155/2013/92829023509808
  5. J van LunzenM AltfeldSex differences in infectious diseases-common but neglectedJ Infect Dis2014209SupplS79S8010.1093/infdis/jiu15924966193
  6. NF FishThe X-files in immunity: sex-based differences predispose immune responsesNat Rev Immunol.2008873473710.1038/nri2394
  7. SL KleinA JedlickaA PekoszThe Xs and Y of immune responses to viral vaccinesLancet Infect Dis20101033834910.1016/S1473-3099(10)70049-920417416
  8. LM PennellCL GalliganEN FishSex affects immunityJ Autoimmun201238J282J29110.1016/j.jaut.2011.11.01322225601
  9. I Camacho-ArroyoV Hansberg-PastorER Vázquez-MartínezM Cerbón3.10––mechanism of progesterone action in the brainHormones, Brain and Behavior2017181214
  10. MA SaderKC McGrathMD HillKF BradstockM JimenezDJ HandelsmanAndrogen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesisClin Endocrinol200562566310.1111/j.1365-2265.2004.02173.x
  11. MK AngeleMG SchwachaA AyalaIH ChaudryEffect of gender and sex hormones on immune responses following shockShock200014819010.1097/00024382-200014020-0000110947147
  12. N HeldringA PikeS AnderssonJ MatthewsG ChengJ HartmanEstrogen receptors: how do they signal and what are their targetsPhysiol Rev20078790593110.1152/physrev.00026.200617615392
  13. J Szekeres-BarthoA BarakonyiG ParB PolgarT PalkovicsL SzeredayProgesterone as an immunomodulatory moleculeInt Immunopharmacol200111037104810.1016/S1567-5769(01)00035-211407300
  14. DP RobinsonSL KleinPregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesisHorm Behav20126226327110.1016/j.yhbeh.2012.02.02322406114
  15. E KalkhovenS WissinkPT van der SaagB van der BurgNegative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptorJ Biol Chem19962716217622410.1074/jbc.271.11.62178626413
  16. S HiranoD FurutamaT HanafusaPhysiologically high concentrations of 17beta-estradiol enhance NF-kappaB activity in human T cellsAm J Physiol Regul Integr Comp Physiol2007292R1465R147110.1152/ajpregu.00778.200617194723
  17. A TrigunaiteJ DimoTN JørgensenSuppressive effects of androgens on the immune systemCell Immunol2015294879410.1016/j.cellimm.2015.02.00425708485
  18. J SchröderV KahlkeKH StaubachP ZabelF StüberGender differences in human sepsisArch Surg19981331200120510.1001/archsurg.133.11.12009820351
  19. CM GrimaldiL HillX XuE PeevaB DiamondHormonal modulation of B cell development and repertoire selectionMol Immunol20054281182010.1016/j.molimm.2004.05.01415829269
  20. I MarriottKL BostYM Huet-HudsonSexual dimorphism in expression of receptors for bacterial lipopolysaccharides in murine macrophages: a possible mechanism for gender-based differences in endotoxic shock susceptibilityJ Reprod Immunol200671122710.1016/j.jri.2006.01.00416574244
  21. TS BlackwellJW ChristmanSepsis and cytokines: current statusBr J Anaesth19967711011710.1093/bja/77.1.1108703620
  22. LS AckermanSex hormones and the genesis of autoimmunityArch Dermatol200614237137616549717
  23. SV AulockS DeiningerC DraingK GueinziusO DehusC HermannGender difference in cytokine secretion on immune stimulation with LPS and LTAJ Interf Cytokine Res20062688789210.1089/jir.2006.26.887
  24. EE McClellandJM SmithGender specific differences in the immune response to infectionArch Immunol Ther Exp20115920321310.1007/s00005-011-0124-3
  25. C Giefing-KrollP BergerG LepperdingerB Grubeck-LoebensteinHow sex and age affect immune responses, susceptibility to infections, and response to vaccinationAging Cell20151430932110.1111/acel.1232625720438
  26. T GiglioMA ImroG FilaciM ScudelettiF PuppoL De CeccoImmune cell circulating subsets are affected by gonadal functionLife Sci1994541305131210.1016/0024-3205(94)00508-78190002
  27. S KumruA GodekmerdanB YilmazImmune effects of surgical menopause and estrogen replacement therapy in peri-menopausal womenJ Reprod Immunol200463313810.1016/j.jri.2004.02.00115284002
  28. I MarriottYM Huet-HudsonSexual dimorphism in innate immune responses to infectious organismsImmunol Res20063417719210.1385/IR:34:3:17716891670
  29. T YasuiM MaegawaJ TomitaY MiyataniM YamadaH UemuraChanges in serum cytokine concentrations during the menopausal transitionMaturitas20075639640310.1016/j.maturitas.2006.11.00217164077
  30. M KhanA plausible explanation for male dominance in typhoid ileal perforationClin Exp Gastroenterol2012521321710.2147/CEG.S3656923180972
  31. H HommaE HoyDZ XuQ LuR FeinmanEA DeitchThe female intestine is more resistant than the male intestine to gut injury and inflammation when subjected to conditions associated with shock statesAm J Physiol Gastrointest Liver Physiol2005288G466G47210.1152/ajpgi.00036.200415499084
  32. T KawasakiT SuzukiMA ChoudhryKI BlandIH ChaudrySalutary effects of 17beta-estradiol on Peyer’s patch T cell functions following trauma-hemorrhageCytokine20105116617210.1016/j.cyto.2010.03.01620400328
  33. SL KleinKL FlanaganSex differences in immune responsesNat Rev Immunol20161662663810.1038/nri.2016.9027546235
  34. M FaasA BoumanH MoesaMJ HeinemanL de LeijG SchuilingThe immune response during the luteal phase of the ovarian cycle: a Th2-type response?Fertil Steril2000741008101310.1016/S0015-0282(00)01553-311056250
  35. Strauss JF. The synthesis and metabolism of steroid hormones. In: Yen, Jaffe’s, editors. Reproductive Endocrinology. Philadelphia: Elsevier; 2014. p. 66–92.e3.
  36. RS ScotlandMJ StablesS MadalliP WatsonDW GilroySex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female miceBlood20111185918592710.1182/blood-2011-03-34028121911834
  37. NJ StrachanRO WatsonV NovikD HofreuterID OgdenJE GalanSexual dimorphism in campylobacteriosisEpidemiol Infect20081361492149510.1017/S095026880700993418062834
  38. NO KaakoushN Castano-RodriguezHM MitchellSM ManGlobal epidemiology of campylobacter infectionClin Microbiol Rev20152868772010.1128/CMR.00006-1526062576
  39. C de MartelJ ParsonnetHelicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveysDig Dis Sci2006512292230110.1007/s10620-006-9210-517089189
  40. J KhatoonRP RaiKN PrasadRole of helicobacter pylori in gastric cancer: updatesWorld J Gastrointest Oncol2016814715810.4251/wjgo.v8.i2.14726909129
  41. M Campbell-ThompsonGY LauwersKK ReyherJ CromwellKT Shiverick17Beta-estradiol modulates gastroduodenal preneoplastic alterations in rats exposed to the carcinogen N-methyl-N’-nitro-nitrosoguanidineEndocrinology19991404886489410.1210/endo.140.10.703010499548
  42. M OhtaniG ZhongmingA GarcíaAB RogersS MuthupalaniNS Taylor17β-estradiol suppresses helicobacter pylori-induced gastric pathology in male hypergastrinemic INS-GAS miceCarcinogenesis2011321244125010.1093/carcin/bgr07221565825
  43. C MessaF RussoM PricciA Di LeoEpidermal growth factor and 17beta-estradiol effects on proliferation of a human gastric cancer cell line (AGS)Scand J Gastroenterol20003575375810.1080/00365520075002344410972181
  44. V MartinetiL PicarielloI TognariniS Carbonell SalaA GozziniC AzzariERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle componentsEndocr Relat Cancer20051245546910.1677/erc.1.0086115947116
  45. JY LuP JinW GaoDZ WangJQ ShengEstrogen enhances mismatch repair by induction of MLH1 expression via estrogen receptor-betaOncotarget20178387673877928404976
  46. ME KableLM HansenCM StyerSL DeckO RakhimovaA ShevtsovaHost determinants of expression of the helicobacter pylori BabA adhesinSci Rep201774649910.1038/srep4649928418004
  47. VA PotterA AravinthanIdentifying patients at risk of severe Clostridium difficile-associated diseaseBr J Hosp Med20127326527010.12968/hmed.2012.73.5.265
  48. J Silva-VelazcoTL HullC MessickJM ChurchMedical versus surgical patients with Clostridium difficile infection: is there any difference?Am Surg2016821155115928234177
  49. R DasP FeuerstadtLJ BrandtGlucocorticoids are associated with increased risk of short-term mortality in hospitalized patients with clostridium difficile-associated diseaseAm J Gastroenterol20101052040204910.1038/ajg.2010.14220389295
  50. M LigginsN RamirezN MagnusonE Abel-SantosProgesterone analogs influence germination of Clostridium sordellii and Clostridium difficile spores in vitroJ Bacteriol20111932776278310.1128/JB.00058-1121478359
  51. A Bancerz-KisielW SzwedaYersiniosis––a zoonotic foodborne disease of relevance to public healthAnn Agric Env Med20152239740210.5604/12321966.116770026403101
  52. BM RosnerK StarkD WerberEpidemiology of reported Yersinia enterocolitica infections in Germany, 2001–2008BMC Public Health20101033710.1186/1471-2458-10-33720546575
  53. W RastawickiA JakubczakSerum immunoglobulin IgG subclass distribution of antibody responses to Yop proteins and lipopolysaccharide of Yersinia enterocolitica in patients with yersiniosisPol J Microbiol20075623323818254492
  54. RC AalberseR van der GaagJ van LeeuwenSerologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted responseJ Immunol19831307227266600252
  55. RC AalberseSO StapelJ SchuurmanT RispensImmunoglobulin G4: an odd antibodyClin Exp Allergy20093946947710.1111/j.1365-2222.2009.03207.x19222496
  56. M SatohH TomaS KiyunaY ShiromaA KokazeY SatoAssociation of a sex-related difference of Strongyloides stercoralis-specific IgG4 antibody titer with the efficacy of treatment of strongyloidiasisAm J Trop Med Hyg20047110711115238698
  57. WG HladyKC KlontzThe epidemiology of vibrio infections in Florida, 1981-1993J Infect Dis19961731176118310.1093/infdis/173.5.11768627070
  58. FR ChowdhuryZ NurN HassanL von SeidleinS DunachiePandemics, pathogenicity and changing molecular epidemiology of cholera in the era of global warmingAnn Clin Microbiol Antimicrob2017161010.1186/s12941-017-0185-128270154
  59. N EshimaO TokumaruS HaraK BacalS KorematsuS KarukayaAge-specific sex-related differences in infections: a statistical analysis of national surveillance data in JapanPLoS One20127e4226110.1371/journal.pone.004226122848753
  60. WC LeeYH KwonComparative study on the epidemiological aspects of enterohemorrhagic Escherichia coli infections between Korea and Japan, 2006 to 2010Korean J Intern Med20163157958410.3904/kjim.2014.25526886212
  61. C FrankD WerberJP CramerM AskarM FaberM an der HeidenEpidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in GermanyN Engl J Med20113651771178010.1056/NEJMoa110648321696328
  62. JK MarshallM ThabaneAX GargWF ClarkM SalvadoriSM CollinsIncidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysenteryGastroenterology200613144545010.1053/j.gastro.2006.05.05316890598
  63. J Schwille-KiuntkeP EnckC ZendlerM KriegAV PolsterS KlosterhalfenPostinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or CampylobacterNeurogastroenterol Motil201123e479e48810.1111/j.1365-2982.2011.01779.x21883703
  64. S BharadwajMD BarberLA GraffB ShenSymptomatology of irritable bowel syndrome and inflammatory bowel disease during the menstrual cycleGastroenterol Rep2015318519310.1093/gastro/gov010
  65. O ZierauAC ZenclussenF JensenRole of female sex hormones, estradiol and progesterone, in mast cell behaviorFront Immunol2012316910.3389/fimmu.2012.0016922723800
  66. HS GordonGE RosenthalThe relationship of gender and in-hospital death: increased risk of death in menMed Care19993731832410.1097/00005650-199903000-0001110098575
  67. ME FalagasEG MourtzoukouKZ VardakasSex differences in the incidence and severity of respiratory tract infectionsRespir Med20071011845186310.1016/j.rmed.2007.04.01117544265
  68. H AssaggafQ FeltyGender, estrogen, and obliterative lesions in the lungInt J Endocrinol2017201711310.1155/2017/8475701
  69. SI SheikhD HayesSE KirkbyJD TobiasD TuminAge-dependent gender disparities in post lung transplant survival among patients with idiopathic pulmonary fibrosisAnn Thorac Surg201710344144610.1016/j.athoracsur.2016.08.08328341270
  70. S CohenSocial status and susceptibility to respiratory infectionsAnn N Y Acad Sci199989624625310.1111/j.1749-6632.1999.tb08119.x10681901
  71. MM HaenleSO BrockmannM KronU BertlingRA MasonG SteinbachOverweight, physical activity, tobacco and alcohol consumption in a cross-sectional random sample of German adultsBMC Public Health2006623310.1186/1471-2458-6-23316981990
  72. LEA Kivihya-NduggaMRA van CleeffLW Ng’ang’aH MemeJA OdhiamboPR KlatserSex-specific performance of routine TB diagnostic testsInt J Tuberc Lung Dis2005929430015786893
  73. M GleesonN BishopM OliveiraT McCauleyP TaulerSex differences in immune variables and respiratory infection incidence in an athletic populationExerc Immunol Rev20111712213521446355
  74. Y ChenR DalesM LinThe epidemiology of chronic rhinosinusitis in CanadiansLaryngoscope20031131199120510.1097/00005537-200307000-0001612838019
  75. R GuptaPJ HelmsIT JolliffeAS DouglasSeasonal variation in sudden infant death syndrome and bronchiolitis––a common mechanism?Am J Respir Crit Care Med199615443143510.1164/ajrccm.154.2.87568188756818
  76. Abid S, Xie S, Bose M, Shaul PW, Terada LS, Brody SL, et al. 17β-estradiol dysregulates innate immune responses to Pseudomonas aeruginosa respiratory infection and is modulated by estrogen receptor antagonism. Payne SM, editor Infect Immun 2017;85:e00422–e00417.
  77. S CuzzocreaS SantagatiL SautebinE MazzonG CalabròI Serraino17beta-estradiol antiinflammatory activity in carrageenan-induced pleurisyEndocrinology20001411455146310.1210/endo.141.4.740410746650
  78. AA AliLN DiebelDM LiberatiEstrogen modulation of pneumonia? An immunoglobulin A effectJ Trauma Acute Care Surg20127290891510.1097/TA.0b013e318246898922491603
  79. F GutiérrezM MasiáC MireteB SoldánJC RodríguezS PadillaThe influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogensJ Inf Secur200653166174
  80. WP KohMB TaylorK HughesSK ChewCW FongMC PhoonSeroprevalence of IgG antibodies against chlamydia pneumoniae in Chinese, Malays and Asian Indians in SingaporeInt J Epidemiol2002311001100710.1093/ije/31.5.100112435775
  81. A KadiogluAM CupponeC TrappettiT ListA SpreaficoG PozziSex-based differences in susceptibility to respiratory and systemic pneumococcal disease in miceJ Infect Dis20112041971197910.1093/infdis/jir65722021621
  82. I Rivero-CalleJ Pardo-SecoP AldazDA VargasE MascarósE RedondoIncidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project)BMC Infect Dis20161664510.1186/s12879-016-1974-427821085
  83. Tamayo E, Montes M, Vicente D, Pérez-Trallero E. Streptococcus pyogenes pneumonia in adults: clinical presentation and molecular characterization of isolates 2006–2015. Chaussee MS, editor PLoS One. 2016;11:e0152640.
  84. AF SimonettiC Garcia-VidalD ViasusD Garcia-SomozaJ DorcaF GudiolDeclining mortality among hospitalized patients with community-acquired pneumoniaClin Microbiol Infect201622567.e1567.e710.1016/j.cmi.2016.03.01527021421
  85. E BackhausS BergR AnderssonG OckbornP MalmströmM DahlEpidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factorsBMC Infect Dis20161636710.1186/s12879-016-1648-227487784
  86. V CukicA HadzicThe most common detected bacteria in sputum of patients with community acquired pneumonia (CAP) treated in hospitalMed Arch (Sarajevo, Bosnia Herzegovina)201670354358
  87. T IshidaA ItoY WashioA YamazakiM NoyamaF TokiokaRisk factors for drug-resistant pathogens in immunocompetent patients with pneumonia: evaluation of PES pathogensJ Infect Chemother201723232810.1016/j.jiac.2016.09.00227729192
  88. E PrinaOT RanzaniE PolverinoC CillónizM FerrerL FernandezRisk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumoniaAnn Am Thorac Soc20151215316010.1513/AnnalsATS.201407-305OC25521229
  89. C CillónizA GabarrúsM FerrerJ Puig de la BellacasaM RinaudoJ MensaCommunity-acquired pneumonia due to multidrug- and non-multidrug-resistant Pseudomonas aeruginosaChest201615041542510.1016/j.chest.2016.03.04227060725
  90. L LorenteA JiménezS PalmeroJJ JiménezJL IribarrenM SantanaComparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart reviewClin Ther2007292433243910.1016/j.clinthera.2007.11.00318158083
  91. F JaimesG De La RosaE GómezP MúneraJ RamírezS CastrillónIncidence and risk factors for ventilator-associated pneumonia in a developing country: where is the difference?Respir Med200710176276710.1016/j.rmed.2006.08.00817027247
  92. J CarceyP GarciaO PadillaJA Castro-RodriguezIncreased prevalence of Mycoplasma pneumoniae serological positivity in Chilean young childrenAllergol Immunopathol (Madr)20164446747110.1016/j.aller.2016.02.00727240442
  93. S NhamoyebondeA LeslieBiological differences between the sexes and susceptibility to tuberculosisJ Infect Dis2014209SupplS100S10610.1093/infdis/jiu14724966189
  94. P NarasimhanJ WoodCR MacintyreD MathaiRisk factors for tuberculosisPulm Med2013201382893910.1155/2013/82893923476764
  95. M-E Jiménez-CoronaL García-GarcíaK DeRiemerL Ferreyra-ReyesM Bobadilla-del-ValleB Cano-ArellanoGender differentials of pulmonary tuberculosis transmission and reactivation in an endemic areaThorax20066134835310.1136/thx.2005.04945216449260
  96. Ephrem T, Mengiste B, Mesfin F, Godana W. Determinants of active pulmonary tuberculosis in Ambo Hospital, West Ethiopia. African J Prim Heal Care Fam Med. 2015;7 10.4102/phcfm.v7i1.608.
  97. Hong EP, Go MJ, Kim H-L, Park JW. Risk prediction of pulmonary tuberculosis using genetic and conventional risk factors in adult Korean population. Ahuja SK, editor PLoS One. 2017;12:e0174642.
  98. KC HortonP MacPhersonRMGJ HoubenRG WhiteEL CorbettSex differences in tuberculosis burden and notifications in low- and middle-income countries: a systematic review and meta-analysisPLoS Med Public Libr Sci201613e100211910.1371/journal.pmed.1002119
  99. R BhurayanontachaiK ManeenilFactors influencing development and mortality of acute respiratory failure in hospitalized patient with active pulmonary tuberculosis: a 10-year retrospective reviewJ Thorac Dis201681721173010.21037/jtd.2016.06.2227499962
  100. CD NnadiLF AndersonLR ArmstrongHR StaggD PedrazzoliR PrattMind the gap: TB trends in the USA and the UK, 2000–2011Thorax20167135636310.1136/thoraxjnl-2015-20791526907187
  101. AH KhanM IsrarA KhanRA AftabTM KhanSmoking on treatment outcomes among tuberculosis patientsAm J Med Sci201534950550910.1097/MAJ.000000000000047326030612
  102. L PimpinLN DrumrightME KruijshaarI AbubakarB RiceV DelpechTuberculosis and HIV co-infection in European Union and European Economic Area countriesEur Respir J2011381382139210.1183/09031936.0019841021737549
  103. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. Williams B, editor PLoS Med. 2008;5:e152.
  104. Cabrera-Gaytán DA, Niebla-Fuentes MDR, Padilla-Velázquez R, Valle-Alvarado G, Arriaga-Nieto L, Rojas-Mendoza T, et al. Association of pulmonary tuberculosis and HIV in the Mexican Institute of Social Security, 2006–2014. Caylà JA, editor PLoS One. 2016;11:e0168559.
  105. SJ RhodesGM KnightK FieldingTJ ScribaAA PathanH McShaneIndividual-level factors associated with variation in mycobacterial-specific immune response: gender and previous BCG vaccination statusTuberculosis201696374310.1016/
  106. K ChavezR RavindranA DehnadIH KhanGender biased immune-biomarkers in active tuberculosis and correlation of their profiles to efficacy of therapyTuberculosis201699172410.1016/
  107. J BrownK ClarkC SmithJ HopwoodO LynardM ToolanVariation in C-reactive protein response according to host and mycobacterial characteristics in active tuberculosisBMC Infect Dis20161626510.1186/s12879-016-1612-127287260
  108. G RamachandranHK Agibothu KupparamC VedhachalamK ThiruvengadamV RajagandhiA DusthackeerFactors influencing tuberculosis treatment outcome in adult patients treated with thrice-weekly regimens in IndiaAntimicrob Agents Chemother201761e02464e0241610.1128/AAC.02464-1628242663
  109. O NeyrollesL Quintana-MurciSexual inequality in tuberculosisPLoS Med20096e100019910.1371/journal.pmed.100019920027210
  110. A StivalE ChiappiniC MontagnaniE OrlandiniC BuzzoniL GalliSexual dimorphism in tuberculosis incidence: children cases compared to adult cases in Tuscany from 1997 to 2011PLoS One20149e10527710.1371/journal.pone.010527725255233
  111. JB HamiltonGE MestlerMortality and survival: comparison of eunuchs with intact men and women in a mentally retarded populationJ Gerontol19692439541110.1093/geronj/24.4.3955362349
  112. L SvanbergEffects of estrogen deficiency in women castrated when youngActa Obstet Gynecol Scand Suppl198110611156951872
  113. N DalgicD TekinZ KayaaltiE CakirT SoylemezogluM SancarRelationship between toll-like receptor 8 gene polymorphisms and pediatric pulmonary tuberculosisDis Markers201131333810.1155/2011/54597221846947
  114. J BustamanteC PicardS Boisson-DupuisL AbelJ-L CasanovaGenetic lessons learned from X-linked Mendelian susceptibility to mycobacterial diseasesAnn N Y Acad Sci201112469210110.1111/j.1749-6632.2011.06273.x22236433
  115. ED ChanMD IsemanSlender, older women appear to be more susceptible to nontuberculous mycobacterial lung diseaseGend Med.2010751810.1016/j.genm.2010.01.00520189150
  116. J DanleyR KwaitDD PetersonJ SendeckiB VaughnK NakisbendiNormal estrogen, but low dehydroepiandrosterone levels, in women with pulmonary Mycobacterium avium complex. A preliminary studyAnn Am Thorac Soc20141190891410.1513/AnnalsATS.201312-422OC24963545
  117. Y YamamotoH SaitoT SetogawaH TomiokaSex differences in host resistance to Mycobacterium marinum infection in miceInfect Immun199159408940961937768
  118. Y YamamotoH TomiokaK SatoH SaitoY YamadaT SetogawaSex differences in the susceptibility of mice to infection induced by Mycobacterium intracellulareAm Rev Respir Dis199014243043310.1164/ajrccm/142.2.4302382907
  119. K TsuyuguchiK SuzukiH MatsumotoE TanakaR AmitaniF KuzeEffect of oestrogen on Mycobacterium avium complex pulmonary infection in miceClin Exp Immunol200112342843410.1046/j.1365-2249.2001.01474.x11298130
  120. EI BiniD Mata EspinosaB Marquina CastilloJ Barrios PayánD ColucciAF CruzThe influence of sex steroid hormones in the immunopathology of experimental pulmonary tuberculosisPLoS One2014921010.1371/journal.pone.0093831
  121. L KleynhansN Du PlessisN AllieM JacobsM KiddPD van HeldenThe contraceptive depot medroxyprogesterone acetate impairs mycobacterial control and inhibits cytokine secretion in mice infected with Mycobacterium tuberculosisInfect Immun2013811234124410.1128/IAI.01189-1223381991
  122. JR López-OlveraIG Fernández-de-MeraE SerranoD VidalJ VicenteY FierroSex-related differences in body condition and serum biochemical parameters in red deer (Cervus elaphus) naturally infected with Mycobacterium bovisVet J201319870270610.1016/j.tvjl.2013.10.00224262346
  123. a J TomlinsonM a ChambersGJ WilsonR a McdonaldRJ DelahaySex-related heterogeneity in the life-history correlates of mycobacterium bovis infection in european badgers (Meles meles)Transbound Emerg Dis201360374510.1111/tbed.1209724171847
  124. D WilkinsonGC SmithRJ DelahayLM RogersCL CheesemanRS Clifton-HadleyThe effects of bovine tuberculosis (Mycobacterium bovis) on mortality in a badger (Meles meles) population in EnglandJ Zool200025038939510.1111/j.1469-7998.2000.tb00782.x
  125. AL YanceyHL WatsonSC CartnerJW SimeckaGender is a major factor in determining the severity of mycoplasma respiratory disease in miceInfect Immun2001692865287110.1128/IAI.69.5.2865-2871.200111292700
  126. L WallisP RobinsonSoil as a source of Legionella pneumophila serogroup 1 (Lp1)Aust N Z J Public Health20052951852010.1111/j.1467-842X.2005.tb00242.x16366061
  127. P DeclerckJ BehetsV van HoefF OllevierDetection of Legionella spp. and some of their amoeba hosts in floating biofilms from anthropogenic and natural aquatic environmentsWater Res2007413159316710.1016/j.watres.2007.04.01117544473
  128. CA JosephLegionnaires’ disease in Europe 2000–2002Epidemiol Infect200413241742410.1017/S095026880400201815188711
  129. AL BeninRF BensonRE BesserTrends in legionnaires disease, 1980–1998: declining mortality and new patterns of diagnosisClin Infect Dis2002351039104610.1086/34290312384836
  130. C QuinnA DemirjianLF WatkinsS TomczykC LucasE BrownLegionnaires’ disease outbreak at a long-term care facility caused by a cooling tower using an automated disinfection system––Ohio, 2013J Environ Health20157881326738313
  131. H Stypułkowska-MisiurewiczM CzerwińskiLegionellosis in Poland in 2012Przegl Epidemiol201468221922125135503
  132. PL ElverdalCS JørgensenKA KrogfeltSA UldumTwo years’ performance of an in-house ELISA for diagnosis of legionnaires’ disease: detection of specific IgM and IgG antibodies against Legionella pneumophila serogroup 1, 3 and 6 in human serumJ Microbiol Methods201394949710.1016/j.mimet.2013.04.01023657054
  133. A AngrupR ChaudhryS SharmaA ValavaneK PassiK PadmajaApplication of real-time quantitative polymerase chain reaction assay to detect Legionella pneumophila in patients of community-acquired pneumonia in a tertiary care hospitalIndian J Med Microbiol20163453910.4103/0255-0857.19535327934840
  134. C ChidiacD CheS Pires-CronenbergerS JarraudC CampèseA BisseryFactors associated with hospital mortality in community-acquired legionellosis in FranceEur Respir J20123996397010.1183/09031936.0007691122005914
  135. J GómezJ MòdolM García-NúñezV BañosM LorenzoML Pedro-BotetLow mortality rate in an outbreak of Legionnaires’ disease: correlation with the cytopathogenity studyMed Clin (Barc)200913332532910.1016/j.medcli.2009.05.01619595380
  136. V NgP TangF JamiesonC GuyardDE LowDN FismanLaboratory-based evaluation of legionellosis epidemiology in Ontario, Canada, 1978 to 2006BMC Infect Dis200996810.1186/1471-2334-9-6819460152
  137. K NeilR BerkelmanIncreasing incidence of legionellosis in the United States, 1990–2005: changing epidemiologic trendsClin Infect Dis20084759159910.1086/59055718665818
  138. N MatsumotoT SasakiH NakaoT KatohY FukudaM NakazatoAn outbreak of Legionnaires’ disease associated with a circulating bathwater system at a public bathhouse. II: radiological findings of pneumoniaJ Infect Chemother20081412312910.1007/s10156-008-0591-618622675
  139. JW den BoerIHM FriesemaJD HooiReported cases of Legionella pneumonia in the Netherlands, 1987–2000Ned Tijdschr Geneeskd200214631532011876036
  140. JS LiED O’BrienC GuestA review of national legionellosis surveillance in Australia, 1991 to 2000Commun Dis Intell Q Rep20022646146812416715
  141. B-S HanM-J LeeY-H KwonW-C LeeA comparative study of the epidemiological aspects of Legionnaires’ disease: outbreaks in Korea and Japan, 2010–2014J Clin Med Res20179677010.14740/jocmr2811e27924178
  142. M RosenfeldR DavisS FitzSimmonsM PepeB RamseyGender gap in cystic fibrosis mortalityAm J Epidemiol199714579480310.1093/oxfordjournals.aje.a0091729143209
  143. KJ RamosBS QuonSL HeltsheN Mayer-HamblettED LeaseML AitkenHeterogeneity in survival in adult patients with cystic fibrosis with FEV 1 < 30% of predicted in the United StatesChest20171511320132810.1016/j.chest.2017.01.01928115168
  144. FS MagnetJ CallegariD DieninghoffM SpielmannsJH StorreC SchmoorImpact of Pseudomonas aeruginosa infection on respiratory muscle function in adult cystic fibrosis patientsRespiration201793425010.1159/00045289327875809
  145. M JohannessonD LúdvíksdóttirC JansonLung function changes in relation to menstrual cycle in females with cystic fibrosisRespir Med2000941043104610.1053/rmed.2000.089111127489
  146. SH ChotirmallSG SmithC GunaratnamS CosgroveBD DimitrovSJ O’NeillEffect of estrogen on pseudomonas mucoidy and exacerbations in cystic fibrosisN Engl J Med20123661978198610.1056/NEJMoa110612622607135
  147. SH ChotirmallCM GreeneIK OglesbyW ThomasSJ O’NeillBJ Harvey17Beta-estradiol inhibits IL-8 in cystic fibrosis by up-regulating secretory leucoprotease inhibitorAm J Respir Crit Care Med2010182627210.1164/rccm.201001-0053OC20378727
  148. C GuilbaultP StotlandC LachanceM TamA KellerL Thompson-SnipesInfluence of gender and interleukin-10 deficiency on the inflammatory response during lung infection with Pseudomonas aeruginosa in miceImmunology200210729730510.1046/j.1365-2567.2002.01508.x12423305
  149. C GuilbaultP MartinD HouleM-L BoghdadyM-C GuiotD MarionCystic fibrosis lung disease following infection with Pseudomonas aeruginosa in Cftr knockout mice using novel non-invasive direct pulmonary infection techniqueLab Anim20053933635210.1258/002367705430694416004694
  150. Y WangE CelaS GagnonNB SweezeyEstrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis miceRespir Res20101116610.1186/1465-9921-11-16621118573
  151. O WynneJC HorvatRY KimLK OngR SmithPM HansbroNeonatal respiratory infection and adult re-infection: effect on glucocorticoid and mineralocorticoid receptors in the hippocampus in BALB/c miceBrain Behav Immun2011251214122210.1016/j.bbi.2011.03.01421440617
  152. SM KennedyR ChambersW DuH Dimich-WardEnvironmental and occupational exposures: do they affect chronic obstructive pulmonary disease differently in women and men?Proc Am Thorac Soc2007469269410.1513/pats.200707-094SD18073405
  153. JM PetersE AvolWJ GaudermanWS LinnW NavidiSJ LondonA study of twelve Southern California communities with differing levels and types of air pollution. II. Effects on pulmonary functionAm J Respir Crit Care Med199915976877510.1164/ajrccm.159.3.980414410051249
  154. M Medina-RamónJ SchwartzWho is more vulnerable to die from ozone air pollution?Epidemiology20081967267910.1097/EDE.0b013e318177347618480732
  155. AN MikerovS HuF DurraniX GanG WangTM UmsteadImpact of sex and ozone exposure on the course of pneumonia in wild type and SP-A (−/−) miceMicrob Pathog Elsevier Ltd20125223924910.1016/j.micpath.2012.01.005
  156. AN MikerovX GanTM UmsteadL MillerVM ChinchilliDS PhelpsSex differences in the impact of ozone on survival and alveolar macrophage function of mice after Klebsiella pneumoniae infectionRespir Res200892410.1186/1465-9921-9-2418307797
  157. AN MikerovR HaqueX GanX GuoDS PhelpsJ FlorosAblation of SP-A has a negative impact on the susceptibility of mice to Klebsiella pneumoniae infection after ozone exposure: sex differencesRespir Res200897710.1186/1465-9921-9-7719055785
  158. N CabelloV MishraU SinhaSL DiAngeloZC ChroneosNA EkpaSex differences in the expression of lung inflammatory mediators in response to ozoneAm J Physiol Lung Cell Mol Physiol2015309L1150L116310.1152/ajplung.00018.201526342085
  159. F DurraniDS PhelpsJ WeiszP SilveyraS HuAN MikerovGonadal hormones and oxidative stress interaction differentially affects survival of male and female mice after lung Klebsiella pneumoniae infectionExp Lung Res20123816517210.3109/01902148.2011.65404522394250
  160. DG RemickPathophysiology of sepsisAm J Pathol20071701435144410.2353/ajpath.2007.06087217456750
  161. CJ GannonLM NapolitanoM PasqualeJK TracyRJ McCarterA statewide population-based study of gender differences in trauma: validation of a prior single-institution studyJ Am Coll Surg2002195111810.1016/S1072-7515(02)01187-012113534
  162. MA ChoudhryKI BlandIH ChaudryGender and susceptibility to sepsis following traumaEndocr Metab Immune Disord Drug Targets2006612713510.2174/18715300677744242216787286
  163. Marini S, Morotti A, Lena UK, Goldstein JN, Greenberg SM, Rosand J, et al. Men experience higher risk of pneumonia and death after intracerebral hemorrhage. Neurocrit Care. 2018;28:77–82.
  164. Humphreys H, Fitzpatick F, Harvey BJ. Gender differences in rates of carriage and bloodstream infection caused by methicillin-resistant Staphylococcus aureus: are they real, do they matter and why? Goldstein EJC, editor Clin Infect Dis. 2015;61:1708–1714.
  165. LJ MooreFA MooreSL JonesJ XuBL BassSepsis in general surgery: a deadly complicationAm J Surg200919886887410.1016/j.amjsurg.2009.05.02519969144
  166. M KisatCV VillegasS OngutiSN ZafarA LatifDT EfronPredictors of sepsis in moderately severely injured patients: an analysis of the National Trauma Data BankSurg Infect201314626810.1089/sur.2012.009
  167. C-C LeeF-Y ChuW-C KoC-H ChiDifferent clinical presentation of community-onset bacteremia among human immunodeficiency virus-infected and human immunodeficiency virus-uninfected adults in the EDAm J Emerg Med2014321241124710.1016/j.ajem.2014.07.02825171801
  168. D JarrarP WangWG CioffiKI BlandIH ChaudryThe female reproductive cycle is an important variable in the response to trauma-hemorrhageAm J Physiol Heart Circ Physiol2000279H1015H102110.1152/ajpheart.2000.279.3.H101510993763
  169. Y MizushimaP WangD JarrarWG CioffiKI BlandIH ChaudryEstradiol administration after trauma-hemorrhage improves cardiovascular and hepatocellular functions in male animalsAnn Surg200023267367910.1097/00000658-200011000-0000911066139
  170. MW WichmannR ZellwegerCM DeMasoA AyalaIH ChaudryMechanism of immunosuppression in males following trauma-hemorrhage: critical role of testosteroneArch Surg19961311186119110.1001/archsurg.1996.014302300680128911259
  171. MW KnöferlD JarrarMK AngeleA AyalaMG SchwachaKI Bland17 beta-estradiol normalizes immune responses in ovariectomized females after trauma-hemorrhageAm J Physiol Cell Physiol.2001281C1131C113810.1152/ajpcell.2001.281.4.C113111546648
  172. D JarrarP WangMW KnöferlJF KueblerWG CioffiKI BlandInsight into the mechanism by which estradiol improves organ functions after trauma-hemorrhageSurgery200012824625210.1067/msy.2000.10737610922999
  173. A MencacciC LeliA CardacciaM MeucciA MorettiF D’AlòProcalcitonin predicts real-time PCR results in blood samples from patients with suspected sepsisPLoS One20127e5327910.1371/journal.pone.005327923300907
  174. A OberholzerM KeelR ZellwegerU SteckholzerO TrentzW ErtelIncidence of septic complications and multiple organ failure in severely injured patients is sex specificJ Trauma20004893293710.1097/00005373-200005000-0001910823539
  175. M FrinkH-C PapeM van GriensvenC KrettekIH ChaudryF HildebrandInfluence of sex and age on mods and cytokines after multiple injuriesShock20072715115610.1097/01.shk.0000239767.64786.de17224789
  176. HE WangNI ShapiroR GriffinMM SaffordS JuddG HowardInflammatory and endothelial activation biomarkers and risk of sepsis: a nested case-control studyJ Crit Care20132854955510.1016/j.jcrc.2012.11.00223414982
  177. C AdrieE AzoulayA FrancaisC Clec’hL DarquesC SchwebelInfluence of gender on the outcome of severe sepsis: a reappraisalChest20071321786179310.1378/chest.07-042017890473
  178. L BindlS BuderusP DahlemS DemirakcaM GoldnerR HuthGender-based differences in children with sepsis and ARDS: the ESPNIC ARDS database groupIntensive Care Med2003291770177310.1007/s00134-003-1948-z12920510
  179. GJ CasimirF HeldenberghL HanssensS MulierC HeinrichsN LefevreGender differences and inflammation: an in vitro model of blood cells stimulation in prepubescent childrenJ Inflamm (Lond)201072810.1186/1476-9255-7-2820525175
  180. R ZellwegerMW WichmannA AyalaS SteinCM DeMasoIH ChaudryFemales in proestrus state maintain splenic immune functions and tolerate sepsis better than malesCrit Care Med19972510611010.1097/00003246-199701000-000218989185
  181. CT NewsomeE FloresA AyalaS GregoryJS ReichnerImproved antimicrobial host defense in mice following poly-(1,6)-β-D-glucopyranosyl-(1,3)-β-D-glucopyranose glucan treatment by a gender-dependent immune mechanismClin Vaccine Immunol2011182043204910.1128/CVI.05202-1121976224
  182. MK AngeleRA CataniaA AyalaWG CioffiKI BlandIH ChaudryDehydroepiandrosterone: an inexpensive steroid hormone that decreases the mortality due to sepsis following trauma-induced hemorrhageArch Surg19981331281128810.1001/archsurg.133.12.12819865644
  183. RA CataniaMK AngeleA AyalaWG CioffiKI BlandIH ChaudryDehydroepiandrosterone restores immune function following trauma-haemorrhage by a direct effect on T lymphocytesCytokine19991144345010.1006/cyto.1998.045810346984
  184. MW WichmannC MüllerG MeyerM AdamMK AngeleSJ EisenmengerDifferent immune responses to abdominal surgery in men and womenLangenbecks Arch Surg200338739740112607118
  185. JA RettewYM Huet-HudsonI MarriottTestosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunityBiol Reprod20087843243710.1095/biolreprod.107.06354518003947
  186. MD DiodatoMW KnöferlMG SchwachaKI BlandIH ChaudryGender differences in the inflammatory response and survival following haemorrhage and subsequent sepsisCytokine20011416216910.1006/cyto.2001.086111396994
  187. S DrechslerK WeixelbaumerP RaevenM JafarmadarA KhademM van GriensvenRelationship between age/gender-induced survival changes and the magnitude of inflammatory activation and organ dysfunction in post-traumatic sepsisPLoS One20127e5145710.1371/journal.pone.005145723251540
  188. JM CarusoDZ XuQ LuSD DayalEA DeitchThe female gender protects against pulmonary injury after trauma hemorrhagic shockSurg Infect2001223124010.1089/109629601317202713
  189. Y-C HsiehM FrinkC-H HsiehMA ChoudhryMG SchwachaKI BlandDownregulation of migration inhibitory factor is critical for estrogen-mediated attenuation of lung tissue damage following trauma-hemorrhageAm J Physiol Lung Cell Mol Physiol.2007292L1227L123210.1152/ajplung.00479.200617277045
  190. Y-C HsiehM FrinkT KawasakiBM ThobeMA ChoudhryMG SchwachaDownregulation of TLR4-dependent ATP production is critical for estrogen-mediated immunoprotection in Kupffer cells following trauma-hemorrhageJ Cell Physiol200721136437010.1002/jcp.2094317219405
  191. Y-C HsiehM FrinkBM ThobeJ-T HsuMA ChoudhryMG Schwacha17Beta-estradiol downregulates Kupffer cell TLR4-dependent p38 MAPK pathway and normalizes inflammatory cytokine production following trauma-hemorrhageMol Immunol2007442165217210.1016/j.molimm.2006.11.01917182102
  192. MK AngeleMW KnöferlA AyalaKI BlandIH ChaudryTestosterone and estrogen differently effect Th1 and Th2 cytokine release following trauma-haemorrhageCytokine200116223010.1006/cyto.2001.094511669583
  193. MK AngeleA AyalaWG CioffiKI BlandIH ChaudryTestosterone: the culprit for producing splenocyte immune depression after trauma hemorrhageAm J Phys1998274C1530C153610.1152/ajpcell.1998.274.6.C1530
  194. S MayrCR WalzP AngeleT Hernandez-RichterIH ChaudryF LoeheCastration prevents suppression of MHC class II (Ia) expression on macrophages after trauma-hemorrhageJ Appl Physiol200610144845310.1152/japplphysiol.00166.200616614359
  195. MK AngeleMW WichmannA AyalaWG CioffiIH ChaudryTestosterone receptor blockade after hemorrhage in males. Restoration of the depressed immune functions and improved survival following subsequent sepsisArch Surg19971321207121410.1001/archsurg.1997.014303500570109366714
  196. F HildebrandBM ThobeWJ HubbardMA ChoudhryH-C PapeIH ChaudryEffects of 17beta-estradiol and flutamide on splenic macrophages and splenocytes after trauma-hemorrhageCytokine20063610711410.1016/j.cyto.2006.11.00217207634
  197. G MoxleyAG SternP CarlsonE EstradaJ HanLL BensonPremenopausal sexual dimorphism in lipopolysaccharide-stimulated production and secretion of tumor necrosis factorJ Rheumatol20043168669415088292
  198. K AsaiN HikiY MimuraT OgawaK UnouM KaminishiGender differences in cytokine secretion by human peripheral blood mononuclear cells: role of estrogen in modulating LPS-induced cytokine secretion in an ex vivo septic modelShock20011634034310.1097/00024382-200116050-0000311699070
  199. SM CoyleSE CalvanoSF LowryGender influences in vivo human responses to endotoxinShock20062653854310.1097/01.shk.0000232589.39001.4d17117126
  200. SM MerkelS AlexanderE ZufallJD OliverYM Huet-HudsonEssential role for estrogen in protection against Vibrio vulnificus-induced endotoxic shockInfect Immun2001696119612210.1128/IAI.69.10.6119-6122.200111553550
  201. T IwasaT MatsuzakiR KinouchiG GereltsetsegM MurakamiM MunkhzayaChanges in central and peripheral inflammatory responses to lipopolysaccharide in ovariectomized female ratsCytokine201465657310.1016/j.cyto.2013.10.00424183967
  202. T IwasaT MatsuzakiS MatsuiA TungalagsuvdM MunkhzayaE TakiguchiThe sensitivity of adipose tissue visfatin mRNA expression to lipopolysaccharide-induced endotoxemia is increased by ovariectomy in female ratsInt Immunopharmacol20163524324710.1016/j.intimp.2016.04.00227083000
  203. H-H ShenS-Y HuangP-Y ChengY-J ChuS-Y ChenK-K LamInvolvement of HSP70 and HO-1 in the protective effects of raloxifene on multiple organ dysfunction syndrome by endotoxemia in ovariectomized ratsMenopause20172495996910.1097/GME.000000000000086428350760
  204. L OngaroD CastrogiovanniA GiovambattistaRC GaillardE SpinediEnhanced proinflammatory cytokine response to bacterial lipopolysaccharide in the adult male rat after either neonatal or prepubertal ablation of biological testosterone activityNeuroimmunomodulation20111825426010.1159/00032412521430397
  205. JA CarrollNC Burdick SanchezLE HulbertMA BallouJW DaileyLC CaldwellSexually dimorphic innate immunological responses of pre-pubertal Brahman cattle following an intravenous lipopolysaccharide challengeVet Immunol Immunopathol201516610811510.1016/j.vetimm.2015.06.00926144890
  206. LT van EijkMJ DorresteijnP SmitsJG van der HoevenMG NeteaP PickkersGender differences in the innate immune response and vascular reactivity following the administration of endotoxin to human volunteersCrit Care Med2007351464146910.1097/01.CCM.0000266534.14262.E817452928
  207. RA HajjehA ReingoldA WeilK ShuttA SchuchatBA PerkinsToxic shock syndrome in the United States: surveillance update, 1979, 1996Emerg Infect Dis1999580781010.3201/eid0506.99061110603216
  208. T ProftJD FraserBacterial superantigensClin Exp Immunol200313329930610.1046/j.1365-2249.2003.02203.x12930353
  209. L FaulknerA CooperC FantinoDM AltmannS SriskandanThe mechanism of superantigen-mediated toxic shock: not a simple Th1 cytokine stormJ Immunol20051756870687710.4049/jimmunol.175.10.687016272345
  210. G AradR LevyR KaempferSuperantigen concomitantly induces Th1 cytokine genes and the ability to shut off their expression on re-exposure to superantigenImmunol Lett200282757810.1016/S0165-2478(02)00021-412008037
  211. L FaulknerDM AltmannS EllmerichI HuhtaniemiG StampS SriskandanSexual dimorphism in superantigen shock involves elevated TNF-alpha and TNF-alpha induced hepatic apoptosisAm J Respir Crit Care Med200717647348210.1164/rccm.200611-1712OC17575097
  212. RS SaiaFM GarciaEC CárnioEstradiol protects female rats against sepsis induced by Enterococcus faecalis improving leukocyte bactericidal activitySteroids2015102172610.1016/j.steroids.2015.06.01626143494
  213. G YeretssianK DoironW ShaoBR LeavittMR HaydenDW NicholsonGender differences in expression of the human caspase-12 long variant determines susceptibility to Listeria monocytogenes infectionProc Natl Acad Sci U S A20091069016902010.1073/pnas.081336210619447924
  214. R ChandraS FedericiZH NémethB HorváthP PacherG HaskóFemale X-chromosome mosaicism for NOX2 deficiency presents unique inflammatory phenotype and improves outcome in polymicrobial sepsisJ Immunol20111866465647310.4049/jimmunol.110020521502376
  215. Z SpolaricsThe X-files of inflammation: cellular mosaicism of X-linked polymorphic genes and the female advantage in the host response to injury and infectionShock20072759760410.1097/SHK.0b013e31802e40bd17505297
  216. R ChandraS FedericiZH NémethB CsókaJA ThomasR DonnellyCellular mosaicism for X-linked polymorphisms and IRAK1 expression presents a distinct phenotype and improves survival following sepsisJ Leukoc Biol20149549750710.1189/jlb.071339724193737
  217. MC ManukyanBR WeilY WangAM AbarbanellJL HerrmannJA PoynterFemale stem cells are superior to males in preserving myocardial function following endotoxemiaAm J Physiol Regul Integr Comp Physiol.2011300R1506R151410.1152/ajpregu.00518.201021451141
  218. M ChamekhM DenyM RomanoN LefèvreF CorazzaJ DuchateauDifferential susceptibility to infectious respiratory diseases between males and females linked to sex-specific innate immune inflammatory responseFront Immunol20178180610.3389/fimmu.2017.0180629321783
  219. SJ EisenmengerMW WichmannP AngeleE FaistR HatzIH ChaudryDifferences in the expression of LPS-receptors are not responsible for the sex-specific immune response after trauma and hemorrhagic shockCell Immunol2004230172210.1016/j.cellimm.2004.08.00215541715
  220. T ShimizuH-P YuY-C HsiehMA ChoudhryT SuzukiKI BlandFlutamide attenuates pro-inflammatory cytokine production and hepatic injury following trauma-hemorrhage via estrogen receptor-related pathwayAnn Surg200724529730410.1097/01.sla.0000232523.88621.1717245185
  221. N SharawyS RibbackN Al-BannaC LehmannH KernM WendtEstradiol receptors agonists induced effects in rat intestinal microcirculation during sepsisMicrovasc Res20138511812710.1016/j.mvr.2012.10.00223063870
  222. T SuzukiT ShimizuH-P YuY-C HsiehMA ChoudhryMG SchwachaTissue compartment-specific role of estrogen receptor subtypes in immune cell cytokine production following trauma-hemorrhageJ Appl Physiol200710216316810.1152/japplphysiol.00964.200617023568
  223. T SuzukiT ShimizuHP YuYC HsiehMA ChoudhryKICI BlandEstrogen receptor-alpha predominantly mediates the salutary effects of 17beta-estradiol on splenic macrophages following trauma-hemorrhageAm J Physiol Cell Physiol2007293C978C98410.1152/ajpcell.00092.200717553937
  224. H-P YuY-C HsiehT SuzukiT ShimizuMA ChoudhryMG SchwachaSalutary effects of estrogen receptor-beta agonist on lung injury after trauma-hemorrhageAm J Physiol Lung Cell Mol Physiol.2006290L1004L100910.1152/ajplung.00504.200516361351
  225. T SuzukiT ShimizuH-P YuY-C HsiehMA ChoudhryIH ChaudrySalutary effects of 17beta-estradiol on T-cell signaling and cytokine production after trauma-hemorrhage are mediated primarily via estrogen receptor-alphaAm J Physiol Cell Physiol.2007292C2103C211110.1152/ajpcell.00488.200617287365
  226. T ShimizuH-P YuT SuzukiL SzalayY-C HsiehMA ChoudhryThe role of estrogen receptor subtypes in ameliorating hepatic injury following trauma-hemorrhageJ Hepatol2007461047105410.1016/j.jhep.2007.01.01917336418
  227. PA CristofaroSM OpalJE PalardyNA ParejoJ JhungJC KeithWAY-202196, a selective estrogen receptor-beta agonist, protects against death in experimental septic shockCrit Care Med2006342188219310.1097/01.CCM.0000227173.13497.5616755255
  228. MK AngeleS PratschkeWJ HubbardIH ChaudryGender differences in sepsis: cardiovascular and immunological aspectsVirulence20145121910.4161/viru.2698224193307
  229. F FabbianA De GiorgiPJ Lopez-SotoM PalaR TiseoR CultreraIs female gender as harmful as bacteria? Analysis of hospital admissions for urinary tract infections in elderly patientsJ Womens Heal20152458759210.1089/jwh.2014.5140
  230. M HarperG Fowlis3. Management of urinary tract infections in menTrends Urol Gynaecol Sex Heal Wiley-Blackwell200712303510.1002/tre.8
  231. C SonnexInfluence of ovarian hormones on urogenital infectionSex Transm Infect199874111910.1136/sti.74.1.119634294
  232. S JareforsL BennetE YouP ForsbergC EkerfeltJ BerglundLyme borreliosis reinfection: might it be explained by a gender difference in immune response?Immunology200611822423210.1111/j.1365-2567.2006.02360.x16771857
  233. D TveitnesK OymarGender differences in childhood Lyme neuroborreliosisBehav Neurol2015201579076226576072
  234. CS MorrisonP BrightEL WongC KwokI YacobsonCA GaydosHormonal contraceptive use, cervical ectopy, and the acquisition of cervical infectionsSex Transm Dis20043156156710.1097/01.olq.0000137904.56037.7015480119
  235. LM HafnerK CunninghamKW BeagleyOvarian steroid hormones: effects on immune responses and Chlamydia trachomatis infections of the female genital tractMucosal Immunol2013685987510.1038/mi.2013.4623860476
  236. SK BosePC GoswamiEnhancement of adherence and growth of Chlamydia trachomatis by estrogen treatment of HeLa cellsInfect Immun1986536466503744558
  237. T AgrawalV VatsPK WallaceS SalhanA MittalCervical cytokine responses in women with primary or recurrent chlamydial infectionJ Interf Cytokine Res20072722122610.1089/jir.2006.0132
  238. E KitaS TakahashiK YasuiS KashibaEffect of estrogen (17 beta-estradiol) on the susceptibility of mice to disseminated gonococcal infectionInfect Immun1985492382432989180
  239. JL EdwardsNeisseria gonorrhoeae survival during primary human cervical epithelial cell infection requires nitric oxide and is augmented by progesteroneInfect Immun2010781202121310.1128/IAI.01085-0920048043
  240. P CossartA LebretonA trip in the “new microbiology” with the bacterial pathogen Listeria monocytogenesFEBS Lett20145882437244510.1016/j.febslet.2014.05.05124911203
  241. B PascheS KalaydjievTJ FranzE KremmerV Gailus-DurnerH FuchsSex-dependent susceptibility to Listeria monocytogenes infection is mediated by differential interleukin-10 productionInfect Immun2005735952596010.1128/IAI.73.9.5952-5960.200516113316
  242. ML SalemG MatsuzakiGA MadkourK NomotoBeta-estradiol-induced decrease in IL-12 and TNF-alpha expression suppresses macrophage functions in the course of Listeria monocytogenes infection in miceInt J Immunopharmacol19992148149710.1016/S0192-0561(99)00027-210458538
  243. M LeoneA HonstettreH LepidiC CapoF BayardD RaoultEffect of sex on Coxiella burnetii infection: protective role of 17beta-estradiolJ Infect Dis200418933934510.1086/38079814722900
  244. J TextorisLH BanC CapoD RaoultM LeoneJL MegeSex-related differences in gene expression following Coxiella burnetii infection in mice: potential role of circadian rhythmPLoS One20105e1219010.1371/journal.pone.001219020730052
  245. JD OliverWound infections caused by Vibrio vulnificus and other marine bacteriaEpidemiol Infect200513338339110.1017/S095026880500389415962544
  246. MA HorsemanS SuraniA comprehensive review of Vibrio vulnificus: an important cause of severe sepsis and skin and soft-tissue infectionInt J Infect Dis201115e157e16610.1016/j.ijid.2010.11.00321177133
  247. HJ ShiauMA ReynoldsSex differences in destructive periodontal disease: exploring the biologic basisJ Periodontol2010811505151710.1902/jop.2010.10004520594052
  248. E CottiA ZeddaM DeiddaA PirasG FloreF IdeoEndodontic infection and endothelial dysfunction are associated with different mechanisms in men and womenJ Endod.20154159460010.1016/j.joen.2015.01.03725799534
  249. MS GomesTC BlattnerM Sant’Ana FilhoFS GreccaFN HugoAF FouadCan apical periodontitis modify systemic levels of inflammatory markers? A systematic review and meta-analysisJ Endod2013391205121710.1016/j.joen.2013.06.01424041380
  250. N MansurR HazzanM PaulJ BisharaL LeiboviciDoes sex affect 30-day mortality in Staphylococcus aureus bacteremia?Gend Med2012946347010.1016/j.genm.2012.10.00923141419
  251. DZ UslanSJ CraneJM SteckelbergFR CockerillJL St SauverWR WilsonAge- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, MinnesotaArch Intern Med200716783483910.1001/archinte.167.8.83417452548
  252. PM VidalPA TrindadeTO GarciaRL PachecoSF CostaC ReinertDifferences between “classical” risk factors for infections caused by methicillin-resistant Staphylococcus aureus (MRSA) and risk factors for nosocomial bloodstream infections caused by multiple clones of the staphylococcal cassette chromosome mec type IV MRSA strainInfect Control Hosp Epidemiol20093013914510.1086/59395419146463
  253. D Carnicer-PontKA BaileyBW MasonAM WalkerMR EvansRL SalmonRisk factors for hospital-acquired methicillin-resistant Staphylococcus aureus bacteraemia: a case-control studyEpidemiol Infect20061341167117310.1017/S095026880600632716623990
  254. DO MaclaytonKJ SudaKA CovalCB YorkKW GareyCase-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysisClin Ther2006281208121610.1016/j.clinthera.2006.08.00316982298
  255. BA SuryatiM WatsonStaphylococcus aureus bacteraemia in children: a 5-year retrospective reviewJ Paediatr Child Health20023829029410.1046/j.1440-1754.2002.00787.x12047699
  256. KB LauplandO LyytikäinenM SøgaardKJ KennedyJD KnudsenC OstergaardThe changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance studyClin Microbiol Infect20131946547110.1111/j.1469-0691.2012.03903.x22616816
  257. AJ KaaschG BarlowJD EdgeworthVG FowlerM HellmichS HopkinsStaphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studiesJ Infect20146824225110.1016/j.jinf.2013.10.01524247070
  258. FC LessaY MuJ DaviesM MurrayM LillieA PearsonComparison of incidence of bloodstream infection with methicillin-resistant Staphylococcus aureus between England and United States, 2006–2007Clin Infect Dis20105192592810.1086/65641420815734
  259. KB LauplandHC SchønheyderKJ KennedyO LyytikäinenL ValiquetteJ GalbraithSalmonella enterica bacteraemia: a multi-national population-based cohort studyBMC Infect Dis2010109510.1186/1471-2334-10-9520398281
  260. C GudiolL CalatayudC Garcia-VidalJ Lora-TamayoM CisnalR DuarteBacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcomeJ Antimicrob Chemother20106533334110.1093/jac/dkp41119959544
  261. B OlesenHJ KolmosF OrskovI OrskovA GottschauBacteraemia due to Escherichia coli in a Danish university hospital, 1986–1990Scand J Infect Dis19952725325710.3109/003655495090190188539550
  262. DS HansenA GottschauHJ KolmosEpidemiology of Klebsiella bacteraemia: a case control study using Escherichia coli bacteraemia as controlJ Hosp Infect19983811913210.1016/S0195-6701(98)90065-29522290
  263. KB LauplandT RossDL ChurchDB GregsonPopulation-based surveillance of invasive pyogenic streptococcal infection in a large Canadian regionClin Microbiol Infect20061222423010.1111/j.1469-0691.2005.01345.x16451408
  264. F LlopisI GrauF TubauM CisnalR PallaresEpidemiological and clinical characteristics of bacteraemia caused by Aeromonas spp. as compared with Escherichia coli and Pseudomonas aeruginosaScand J Infect Dis20043633534110.1080/0036554041002063115287377
The underlying source XML for this text is taken from The license for the article is Creative Commons Attribution 4.0 International. The main subject has been identified as bacterial infectious disease.